Pesticidal Active Heterocyclic Derivatives with Sulfur and Sulfoximine-Containing Substituents.
The development of sulfur- and sulfoximine-containing heterocyclic derivatives addresses the need for improved pesticidal agents by enhancing the efficacy of insecticides and acaricides, providing effective pest control against insects and arthropods.
Patent Information
- Application Number
- JP2022517940
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-07-20
- Filing Date
- 2020-09-17
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-09-17
AI Technical Summary
Existing heterocyclic compounds used as pesticides are not effective against certain pests, particularly insects and arthropods, and there is a need for improved pesticidal agents with enhanced efficacy.
Development of pesticide-active heterocyclic derivatives containing sulfur and sulfoximine substituents, specifically compounds of formula I, which exhibit favorable properties as insecticides and acaricides, including various agrochemically acceptable forms and stereoisomers.
The new derivatives demonstrate improved pesticidal activity against insects and arthropods, offering enhanced control of animal pests with specific substituents that provide effective pest management solutions.
Smart Images

Figure 0007581336000001 
Figure 0007581336000002 
Figure 0007581336000003
Abstract
Description
[Technical field]
[0001] The present invention relates to pesticidally active, in particular insecticidally active, heterocyclic derivatives containing sulfur substituents, processes for their preparation, compositions containing these compounds and their use for controlling arthropods, in particular insects or animal pests, including representatives of the order Acarina. [Background technology]
[0002] Heterocyclic compounds having pesticidal action are known and are described, for example, in WO 2014 / 104407, WO 2016 / 107831, WO 2016 / 107831, WO 2013 / 018928, WO 2014 / 119672, WO 2014 / 119494, WO 2014 / 119679 and WO 2014 / 119670. Summary of the Invention [Means for solving the problem]
[0003] Surprisingly, it has now been found that certain novel pesticidal active derivatives having sulfur and sulfoximine containing substituents have favorable properties as pesticides.
[0004] Thus, the present invention relates to a compound of formula I [ka] (In the formula, G 1 and G 2 are, independently of each other, CH or N; G 3 NCH 3 or O; R 1 is C 1 ~C 6 Alkyl or C 1 ~C 6 is haloalkyl; R 2, H, C 1 ~C 6 Alkyl, C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkyl, -C(O)R 3 or CN; R 3 is C 1 ~C 6 is alkyl; Q is a group of the formulas Qa and Qb [ka] where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A is CH or N; X is S, SO or SO 2 and; R 4 is C 1 ~C 4 is alkyl; R 5 is hydrogen or halogen; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4alkylsulfonyl; and the ring system can contain 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where the ring system cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and said ring system contains 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, wherein said ring system contains at least one ring nitrogen atom and cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; R 6 is a halogen, C 1 ~C 6 Haloalkyl, C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, monosubstituted with cyano 1 ~C 6Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )C(=O)R 10 , -N(R 11 )R 12 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and the ring system can contain 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where the ring system cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4alkylsulfonyl; and said ring system contains at least one ring nitrogen atom and can contain two or three additional ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where said ring system cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; R 7 and R 8 are mutually independent, C 1 ~C 6 is alkyl; R 9 is H or C 1 ~C 6 is alkyl; R 10 is C 1 ~C 6 Alkyl or C 3 ~C 6 is cycloalkyl; R 11 and R 12 are each independently H or C 1 ~C 6 (It is alkyl) or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide of a compound of formula I. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0005] Compounds of formula I having at least one basic centre can be, for example, acid addition salts, for example with strong inorganic acids, for example mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, phosphoric acid or hydrohalic acids, strong organic carboxylic acids, for example C carboxylic acids, which are unsubstituted or substituted, for example, by halogens. 1 ~C 4Alkane carboxylic acids, such as acetic acid, for example saturated or unsaturated dicarboxylic acids, such as oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, for example hydroxycarboxylic acids, such as ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or acid addition salts, for example, with benzoic acid, or organic sulfonic acids, such as C which are unsubstituted or substituted, for example, by halogen. 1 ~C 4 It is possible to form acid addition salts with alkane- or arylsulfonic acids, such as methane- or p-toluenesulfonic acid. Compounds of formula I having at least one acidic group can, for example, form salts with bases, such as inorganic salts, such as alkali metal salts or alkaline earth metal salts, such as sodium salts, potassium salts or magnesium salts, or salts with ammonia or organic amines, such as morpholine, piperidine, pyrrolidine, mono-, di- or tri-lower alkylamines, such as ethyl-, diethyl-, triethyl- or dimethylpropylamine, or mono-, di- or trihydroxy-lower alkylamines, such as mono-, di- or triethanolamine.
[0006] In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as N-oxides or in salt form, for example agriculturally usable salt form.
[0007] N-oxides are the oxidized forms of tertiary amines or nitrogen-containing aromatic heterocyclic compounds. They are described, for example, in the book "Heterocyclic N-oxides", A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
[0008] The compounds of formula I according to the present invention also include the hydrates which may be formed during salt formation.
[0009] As used herein, "C 1 ~C nThe term "alkyl" refers to a saturated straight or branched hydrocarbon group having 1 to n carbon atoms bonded via any of the carbon atoms, such as any one of the following groups: methyl, ethyl, n-propyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, n-pentyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, or 1-ethyl-2-methylpropyl.
[0010] As used herein, "C 1 ~C nThe term "haloalkyl" refers to a linear or branched saturated alkyl group having 1 to n carbon atoms bonded via any of the carbon atoms (as defined above), in which some or all of the hydrogen atoms in these groups may be replaced by fluorine, chlorine, bromine and / or iodine, i.e., for example, chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, "C is one of 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-pentafluoropropyl, heptafluoropropyl, 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl, or nonafluorobutyl. 1 ~C 2 According to the term "-fluoroalkyl", a C-fluoroalkyl group having 1, 2, 3, 4 or 5 fluorine atoms is 1 ~C 2 -refers to an alkyl group such as any one of difluoromethyl, trifluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, or penta-fluoroethyl.
[0011] As used herein, "C 1 ~C nThe term "alkoxy" refers to a straight or branched saturated alkyl group having 1 to n carbon atoms attached via an oxygen atom (as defined above), i.e., any one of methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, or 1,1-dimethylethoxy.
[0012] As used herein, "C 1 ~C n The term "haloalkoxy" refers to any of the above C's partially or fully substituted with fluorine, chlorine, bromine and / or iodine. 1 ~C n alkoxy groups, i.e. for example, chloromethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, 2,2,3,3,3-pentafluoropropoxy, heptafluoropropoxy, 1-(fluoromethyl)-2-fluoroethoxy, 1-(chloromethyl)-2-chloroethoxy, 1-(bromomethyl)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, or 4-bromobutoxy.
[0013] As used herein, "C 1 ~C nThe term "-alkylsulfanyl" refers to a straight or branched saturated alkyl group having 1 to n carbon atoms attached via a sulfur atom (as defined above), i.e., any one of methylthio, ethylthio, n-propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio or 1,1-dimethylethylthio.
[0014] As used herein, "C 1 ~C n The term "alkylsulfinyl" refers to a straight or branched saturated alkyl group having 1 to n carbon atoms bonded via the sulfur atom of a sulfinyl group (as defined above), i.e., any one of, for example, methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, 1-methylethyl-sulfinyl, n-butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethyl-ethylsulfinyl, n-pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methyl-butylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl or 1-ethylpropylsulfinyl.
[0015] As used herein, "C 1 ~C n The term "alkylsulfonyl" refers to a straight or branched saturated alkyl group having 1 to n carbon atoms bonded through the sulfur atom of a sulfonyl group (as defined above), i.e., any one of methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl or t-butylsulfonyl.
[0016] As used herein, "mono-substituted C 1 ~C nThe term "alkyl" refers to a linear or branched saturated alkyl group having 1 to n carbon atoms, substituted with a cyano group (as defined above), such as cyanomethylene, cyanoethylene, 1,1-dimethylcyanomethyl, cyanomethyl, cyanoethyl, and 1-dimethylcyanomethyl.
[0017] As used herein, "mono-cyano substituted C 1 ~C n The term "alkoxy" refers to a linear or branched saturated alkoxy group having 1 to n carbon atoms substituted with a cyano group (as defined above), such as cyanomethoxy, cyanoethyoxy, 1,1-dimethylcyanomethoxy and 1-dimethylcyanomethoxy.
[0018] As used herein, "C 3 ~C 6 The term "cycloalkyl" refers to a 3- to 6-membered cycloalkyl group, such as cyclopropane, cyclobutane, cyclopropane, cyclopentane, and cyclohexane.
[0019] Halogen is generally fluorine, chlorine, bromine or iodine. This applies correspondingly to halogen in combination with other meanings, such as haloalkyl.
[0020] In the context of the present invention, "mono- or poly-substituted" in the definition of a substituent typically means mono- to 5-times substitution, more preferably mono-, di- or tri-substitution, depending on the chemical structure of the substituent.
[0021] In the context of the present invention, examples of "a 5- to 6-membered aromatic ring system bonded via a ring carbon atom, ... and said ring system may contain 1, 2 or 3 ring heteroatoms" are in particular, but are not limited to, phenyl, pyridinyl and pyrimidinyl; preferably phenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrimidin-2-yl, pyrimidin-4-yl and pyrimidin-5-yl.
[0022] In the context of the present invention, examples of "a 5-membered aromatic ring system bonded via a ring nitrogen atom... and said ring system containing 1, 2 or 3 ring heteroatoms" are in particular, but not limited to, pyrazolyl, pyrrolyl, imidazolyl and triazolyl; preferably pyrrol-1-yl, pyrazol-1-yl, triazol-2-yl, 1,2,4-triazol-1-yl, triazol-1-yl and imidazol-1-yl.
[0023] Particular embodiments of the present invention are provided as described below.
[0024] Embodiment 1 provides a compound of formula I, or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof, wherein G 1 , G 2 , G 3 , R 1 , R 2 , R 3 , A, X, Q, R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined above in formula I.
[0025] Embodiment 2 provides a compound according to embodiment 1 or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof, wherein Q is Qa.
[0026] Embodiment 3 provides a compound according to embodiment 1 or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof, wherein Q is Qb.
[0027] Regarding embodiments 1 to 3, G 1 , G 2 , G 3 , R 1 , R 2 , R3 , A, X, R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 Preferred values for in any of these combinations are as set forth below.
[0028] Preferably, G 1 and G 2 Both are N.
[0029] G 1 is CH and G 2 It is also preferred that N.
[0030] G 1 is N and G 2 It is also preferred that is CH.
[0031] Most preferably, G 1 and G 2 Both are CH.
[0032] Preferably, G 3 is O.
[0033] Preferably, R 1 is methyl or trifluoromethyl; most preferably trifluoromethyl.
[0034] Preferably, R 2 , H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, -C(O)R 3 Or cyano.
[0035] More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl.
[0036] Most preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0037] Preferably, R 3 is C 1 ~C 4 alkyl; most preferably, R 3 is methyl.
[0038] Preferably, X is S or SO 2 and most preferably, X is SO 2 It is.
[0039] Preferably, R 4 is C 1 ~C 2 alkyl; most preferably, R 4 is ethyl.
[0040] Preferably, R 5 is hydrogen; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system may contain 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0041] More preferably, R 5 is hydrogen; or R5 is a 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 2 or 3 ring nitrogen atoms.
[0042] More preferably, R 5 is hydrogen; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl (preferably pyrimidinyl) linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl (preferably pyrazolyl and triazolyl) linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0043] More preferably, R 5is hydrogen, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl.
[0044] Most preferably, R 5 is hydrogen, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl or 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0045] Preferably, R 6 is C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, monosubstituted with cyano 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 (In the formula, R 7 and R 8 are mutually independent, C 1 ~C 4 alkyl), -N(R 9 )COR 10 (In the formula, R 9 and R 10 are mutually independent, C 1 ~C 4 alkyl), or R 6 is 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4haloalkyl; and said ring system may contain 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0046] More preferably, R 6 is cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl (preferably pyrimidinyl) attached via a ring carbon atom to the ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl (preferably pyrazolyl and triazolyl) linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0047] Most preferably, R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl.
[0048] Preferably, R 7 and R 8 are mutually independent, C 1 ~C 4 It is an alkyl.
[0049] Most preferably, R 7 and R 8 is methyl.
[0050] Preferably, R 9 is H or C 1 ~C 4 It is an alkyl.
[0051] More preferably, R 9 is H or methyl; most preferably, R 9 is methyl.
[0052] Preferably, R 10 is C 1 ~C 6 alkyl; more preferably, R 10 is C 1 ~C 4 alkyl; most preferably, R 10 is methyl.
[0053] Preferably, R 11 and R 12 are each independently H or C 1 ~C 4 alkyl; most preferably, R 11 and R 12 is methyl.
[0054] One group of compounds according to the present invention is represented by formula I-1 [ka] (In the formula, G 1 , G 2 , R 1 , R 2 , R 3 , A, X, R 4 and R 5 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof; 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0055] In a preferred group of compounds of formula I-1, R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0056] In a more preferred group of compounds of formula I-1, R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0057] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-1a), which is any of the compounds of formula (I-1) or preferred embodiments of compounds of formula (I-1),
[0058] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-1b), which is a compound of formula (I-1) or any of the preferred embodiments of compounds of formula (I-1), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0059] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-1c), which is any of the compounds of formula (I-1) or preferred embodiments of compounds of formula (I-1),
[0060] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-1) or any of the preferred embodiments of compounds of formula (I-1).
[0061] One preferred group of compounds according to this embodiment are compounds of formula (I-1e), which are compounds of formula (I-1) or any of the preferred embodiments of compounds of formula (I-1), wherein A is N.
[0062] Another preferred group of compounds according to this embodiment are compounds of formula (I-1f), which are compounds of formula (I-1) or any of the preferred embodiments of compounds of formula (I-1), wherein A is CH.
[0063] One preferred group of compounds according to this embodiment is 2 is N and G 1 is a compound of formula (I-1g), which is a compound of formula (I-1) or any of the preferred embodiments of the compound of formula (I-1), wherein
[0064] Another preferred group of compounds according to this embodiment are 2 and G 1 are both CH.
[0065] Another preferred group of compounds according to this embodiment are 2 is CH and G 1 is N.
[0066] Another group of compounds according to the invention is represented by formula I-2 [ka] (In the formula, G 1 , G 2 , R 1 , R 2 , R 3 , A, X, R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )COR 10 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0067] In a preferred group of compounds of formula I-2, R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 )2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0068] In a more preferred group of compounds of formula I-2, R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3, 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0069] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-2a), which is any of the compounds of formula (I-2) or preferred embodiments of compounds of formula (I-2),
[0070] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-2b), which is a compound of formula (I-2) or any of the preferred embodiments of compounds of formula (I-2), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0071] Another preferred group of compounds according to this embodiment are those in which X is S or SO2 , preferably SO 2 or a compound of formula (I-2c), which is any of the compounds of formula (I-2) or preferred embodiments of compounds of formula (I-2),
[0072] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-2) or any of the preferred embodiments of compounds of formula (I-2).
[0073] One preferred group of compounds according to this embodiment are compounds of formula (I-2e), which are compounds of formula (I-2) or any of the preferred embodiments of compounds of formula (I-2), wherein A is N.
[0074] Another preferred group of compounds according to this embodiment are compounds of formula (I-2f), which are compounds of formula (I-2) or any of the preferred embodiments of compounds of formula (I-2), wherein A is CH.
[0075] One preferred group of compounds according to this embodiment is 2 is N and G 1 is a compound of formula (I-2g), which is a compound of formula (I-2) or any of the preferred embodiments of the compound of formula (I-2), wherein
[0076] Another preferred group of compounds according to this embodiment are 2 and G 1 are both CH.
[0077] Another preferred group of compounds according to this embodiment are 2 is CH and G 1is N.
[0078] Another group of compounds according to the invention is represented by formula I-3 [ka] (In the formula, G 1 , G 2 , R 1 , R 2 , R 3 , A, X, R 4 and R 5 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof; 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0079] In a preferred group of compounds of formula I-3, R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0080] In a more preferred group of compounds of formula I-3, R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0081] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-3a), which is any compound of formula (I-3) or a preferred embodiment of compound of formula (I-3),
[0082] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-3b), which is a compound of formula (I-3) or any of the preferred embodiments of compounds of formula (I-3), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0083] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-3c), which is any compound of formula (I-3) or a preferred embodiment of compound of formula (I-3),
[0084] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-3) or any of the preferred embodiments of compounds of formula (I-3).
[0085] One preferred group of compounds according to this embodiment are compounds of formula (I-3e), which are compounds of formula (I-3) or any of the preferred embodiments of compounds of formula (I-3), wherein A is N.
[0086] Another preferred group of compounds according to this embodiment are compounds of formula (I-3f), which are compounds of formula (I-3) or any of the preferred embodiments of compounds of formula (I-3), wherein A is CH.
[0087] One preferred group of compounds according to this embodiment is 2 is N and G 1 is a compound of formula (I-3g), which is a compound of formula (I-3) or any of the preferred embodiments of compounds of formula (I-3), wherein
[0088] Another preferred group of compounds according to this embodiment are 2 and G 1 are both CH.
[0089] Another preferred group of compounds according to this embodiment are 2 is CH and G 1 is N.
[0090] Another group of compounds according to the invention is represented by formula I-4 [ka] (In the formula, G 1 , G 2 , R 1 , R 2 , R 3 , A, X, R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof, wherein R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )COR 10 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0091] In a preferred group of compounds of formula I-4, R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3, -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0092] In a more preferred group of compounds of formula I-4, R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 )2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0093] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-4a), which is any of the compounds of formula (I-4) or preferred embodiments of compounds of formula (I-4),
[0094] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-4b), which is a compound of formula (I-4) or any of the preferred embodiments of compounds of formula (I-4), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0095] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-4c), which is any compound of formula (I-4) or a preferred embodiment of compound of formula (I-4),
[0096] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-4d), which is either a compound of formula (I-2) or a compound of preferred embodiments of formula (I-4).
[0097] One preferred group of compounds according to this embodiment are compounds of formula (I-4e), which are compounds of formula (I-4) or any of the preferred embodiments of compounds of formula (I-4), wherein A is N.
[0098] Another preferred group of compounds according to this embodiment are compounds of formula (I-4f), which are compounds of formula (I-4) or any of the preferred embodiments of compounds of formula (I-4), wherein A is CH.
[0099] One preferred group of compounds according to this embodiment is 2 is N and G 1 is a compound of formula (I-4g), which is a compound of formula (I-4) or any of the preferred embodiments of compounds of formula (I-4), wherein
[0100] Another preferred group of compounds according to this embodiment are 2 and G 1 are both CH.
[0101] Another preferred group of compounds according to this embodiment are 2 is CH and G1 is N.
[0102] Another group of compounds according to the invention is represented by formula I-5 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 and R 5 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof; 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0103] In a preferred group of compounds of formula I-5, R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0104] In a more preferred group of compounds of formula I-5, R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0105] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-5a), which is any compound of formula (I-5) or a preferred embodiment of compound of formula (I-5),
[0106] Another preferred group of compounds according to this embodiment are 2H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-5b), which is a compound of formula (I-5) or any of the preferred embodiments of compounds of formula (I-5), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0107] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-5c), which is any compound of formula (I-5) or a preferred embodiment of compound of formula (I-5),
[0108] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-5) or any of the preferred embodiments of compounds of formula (I-5).
[0109] One preferred group of compounds according to this embodiment are compounds of formula (I-5e), which are compounds of formula (I-5) or any of the preferred embodiments of compounds of formula (I-5), wherein A is N.
[0110] Another preferred group of compounds according to this embodiment are compounds of formula (I-5f), which are compounds of formula (I-5) or any of the preferred embodiments of compounds of formula (I-5), wherein A is CH.
[0111] Another group of compounds according to the invention is represented by formula I-6 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )COR 10 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0112] In a preferred group of compounds of formula I-6, R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0113] In a more preferred group of compounds of formula I-6, R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0114] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-6a), which is any compound of formula (I-6) or a preferred embodiment of compound of formula (I-6),
[0115] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-6b), which is a compound of formula (I-6) or any of the preferred embodiments of compounds of formula (I-6), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0116] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-6c), which is any compound of formula (I-6) or a preferred embodiment of compound of formula (I-6),
[0117] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-6) or any of the preferred embodiments of compounds of formula (I-6).
[0118] One preferred group of compounds according to this embodiment are compounds of formula (I-6e), which are compounds of formula (I-6) or any of the preferred embodiments of compounds of formula (I-6), wherein A is N.
[0119] Another preferred group of compounds according to this embodiment are compounds of formula (I-6f), which are compounds of formula (I-6) or any of the preferred embodiments of compounds of formula (I-6), wherein A is CH.
[0120] Another group of compounds according to the invention is represented by formula I-7 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 and R 5 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof; 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0121] In a preferred group of compounds of formula I-7, R 5 is preferably H; or R 5is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0122] In a more preferred group of compounds of formula I-7, R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0123] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3or a compound of formula (I-7a), which is any compound of formula (I-7) or a preferred embodiment of compound of formula (I-7),
[0124] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-7b), which is a compound of formula (I-7) or any of the preferred embodiments of compounds of formula (I-7), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0125] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 , preferably SO 2 or a compound of formula (I-7c), which is any compound of formula (I-7) or a preferred embodiment of compound of formula (I-7),
[0126] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-7) or any of the preferred embodiments of compounds of formula (I-7).
[0127] One preferred group of compounds according to this embodiment are compounds of formula (I-7e), which are compounds of formula (I-7) or any of the preferred embodiments of compounds of formula (I-7), wherein A is N.
[0128] Another preferred group of compounds according to this embodiment are compounds of formula (I-7f), which are compounds of formula (I-7) or any of the preferred embodiments of compounds of formula (I-7), wherein A is CH.
[0129] Another group of compounds according to the invention is represented by formula I-8 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )COR 10 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0130] In a preferred group of compounds of formula I-8, R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0131] In a more preferred group of compounds of formula I-8, R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0132] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3and more preferably, R 1 CF 3 or a compound of formula (I-8a), which is any compound of formula (I-8) or a preferred embodiment of compound of formula (I-8),
[0133] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-8b), which is a compound of formula (I-8) or any of the preferred embodiments of compounds of formula (I-8), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0134] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 and preferably SO 2 or a compound of formula (I-8c), which is any compound of formula (I-8) or a preferred embodiment of compound of formula (I-8),
[0135] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-8) or any of the preferred embodiments of compounds of formula (I-8).
[0136] One preferred group of compounds according to this embodiment are compounds of formula (I-8e), which are compounds of formula (I-8) or any of the preferred embodiments of compounds of formula (I-8), wherein A is N.
[0137] Another preferred group of compounds according to this embodiment are compounds of formula (I-8f), which are compounds of formula (I-8) or any of the preferred embodiments of compounds of formula (I-8), wherein A is CH.
[0138] A prominent group of compounds according to the invention is represented by formula (I-9) [ka] (In the formula, R 2 is as defined in formula I above, and Q is of the formula Qa1 and Qb1 [ka] where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A, R 5 and R 6 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 2 is preferably H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 is C 1 ~C 4 alkyl; preferably, R 3 is methyl.
[0139] In one preferred group of compounds of formula I-9, A is N.
[0140] In another preferred group of compounds of formula I-9, R2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0141] In a particularly preferred group of compounds of formula I-9, R 2 is H, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H or ethyl.
[0142] One preferred group of compounds according to this embodiment are compounds of formula (I-9a), which are compounds of formula (I-9) or any of the preferred embodiments of compounds of formula (I-9), wherein Q is Qa1.
[0143] Another preferred group of compounds according to this embodiment are compounds of formula (I-9b), which are compounds of formula (I-9) or any of the preferred embodiments of compounds of formula (I-9), wherein Q is Qb1.
[0144] In a preferred group of compounds of formula (I-9a), R 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0145] In a more preferred group of compounds of formula (I-9a), R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0146] In a particularly preferred group of compounds of formula (I-9a), R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0147] In a distinct group of compounds of formula (I-9a), R 5is preferably H, unsubstituted C-linked pyrimidinyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; more preferably R 5 is selected from the group consisting of H, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl; even more preferably, R 5 is selected from the group consisting of H, pyrimidin-2-yl, and 1,2,4-triazol-1-yl.
[0148] In a preferred group of compounds of formula (I-9b), R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 (In the formula, R 7 and R 8 are mutually independent, C 1 ~C 4 alkyl), -N(R 9 )COR 10 (In the formula, R 9 and R 10 are mutually independent, C 1 ~C 4 alkyl) or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0149] In a more preferred group of compounds of formula (I-9b), R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0150] In a particularly preferred group of compounds of formula (I-9b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0151] In another particularly preferred group of compounds of formula (I-9b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3, 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl; even more preferably, R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0152] One preferred group of compounds according to this embodiment are compounds of formula (I-9c), which are compounds of formula (I-9) or any of the preferred embodiments of compounds of formula (I-9), wherein A is N.
[0153] Another preferred group of compounds according to this embodiment are compounds of formula (I-9e), which are compounds of formula (I-9) or any of the preferred embodiments of compounds of formula (I-9), wherein A is CH.
[0154] Another group of compounds according to the invention is represented by formula I-10 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 and R 5 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer, or N-oxide thereof; 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0155] In a preferred group of compounds of formula I-10, R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0156] In a more preferred group of compounds of formula I-10, R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0157] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-10a), which is any compound of formula (I-10) or a preferred embodiment of compound of formula (I-10),
[0158] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-10b), which is a compound of formula (I-10) or any of the preferred embodiments of compounds of formula (I-10), wherein is methyl; More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0159] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 and preferably SO 2 or a compound of formula (I-10c), which is any compound of formula (I-10) or a preferred embodiment of compound of formula (I-10),
[0160] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-10) or any of the preferred embodiments of compounds of formula (I-10).
[0161] One preferred group of compounds according to this embodiment are compounds of formula (I-10e), which are compounds of formula (I-10) or any of the preferred embodiments of compounds of formula (I-10), wherein A is N.
[0162] Another preferred group of compounds according to this embodiment are compounds of formula (I-10f), which are compounds of formula (I-10) or any of the preferred embodiments of compounds of formula (I-10), wherein A is CH.
[0163] Another group of compounds according to the invention is represented by formula I-11 [ka] (In the formula, R 1 , R 2 , R 3 , A, X, R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , -N(R 9 )COR 10 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0164] In a preferred group of compounds of formula I-11, R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0165] In a more preferred group of compounds of formula I-11, R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0166] One preferred group of compounds according to this embodiment is R 1 C 1 ~C 4 Alkyl or C 1 ~C 4 haloalkyl; preferably, R 1 CH 3 or CF 3 and more preferably, R 1 CF 3 or a compound of formula (I-11a), which is any compound of formula (I-11) or a preferred embodiment of compound of formula (I-11),
[0167] Another preferred group of compounds according to this embodiment are 2 H, C 1 ~C4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 C 1 ~C 4 alkyl; preferably, R 3 is a compound of formula (I-11b), which is a compound of formula (I-11) or any of the preferred embodiments of compounds of formula (I-11), wherein More preferably, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0168] Another preferred group of compounds according to this embodiment are those in which X is S or SO 2 and preferably SO 2 or a compound of formula (I-11c), which is any compound of formula (I-11) or a preferred embodiment of compound of formula (I-11),
[0169] A further preferred group of compounds according to this embodiment are 4 C 1 ~C 2 alkyl; preferably, R 4 is ethyl, which is a compound of formula (I-11) or any of the preferred embodiments of compounds of formula (I-11).
[0170] One preferred group of compounds according to this embodiment are compounds of formula (I-11e), which are compounds of formula (I-11) or any of the preferred embodiments of compounds of formula (I-11), wherein A is N.
[0171] Another preferred group of compounds according to this embodiment are compounds of formula (I-11f), which are compounds of formula (I-11) or any of the preferred embodiments of compounds of formula (I-11), wherein A is CH.
[0172] A prominent group of compounds according to the invention is represented by the formula (I-12) [ka] (In the formula, R 2 is as defined in formula I above, and Q is of the formula Qa1 and Qb1 [ka] where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A, R 5 and R 6 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 2 is preferably H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 is C 1 ~C 4 alkyl; preferably, R 3 is methyl.
[0173] In one preferred group of compounds of formula I-12, A is N.
[0174] In another preferred group of compounds of formula I-12, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0175] In a particularly preferred group of compounds of formula I-12, R 2 is H, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H or ethyl.
[0176] One preferred group of compounds according to this embodiment are compounds of formula (I-12a), which are compounds of formula (I-12) or any of the preferred embodiments of compounds of formula (I-12), wherein Q is Qa1.
[0177] Another preferred group of compounds according to this embodiment are compounds of formula (I-12b), which are compounds of formula (I-12) or any of the preferred embodiments of compounds of formula (I-12), wherein Q is Qb1.
[0178] In a preferred group of compounds of formula (I-12a), R 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0179] In a more preferred group of compounds of formula (I-12a), R 5 is preferably H; or R 5 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0180] In a particularly preferred group of compounds of formula (I-12a), R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0181] In a distinct group of compounds of formula (I-12a), R 5 is preferably H, unsubstituted C-linked pyrimidinyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; more preferably R 5is selected from the group consisting of H, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl; even more preferably, R 5 is selected from the group consisting of H, pyrimidin-2-yl and 1,2,4-triazol-1-yl; R 5 It is even more preferred if is H.
[0182] In a preferred group of compounds of formula (I-12b), R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 (In the formula, R 7 and R 8 are mutually independent, C 1 ~C 4 alkyl), -N(R 9 )COR 10 (In the formula, R 9 and R 10 are mutually independent, C 1 ~C 4 alkyl) or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0183] In a more preferred group of compounds of formula (I-12b), R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6 is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0184] In a particularly preferred group of compounds of formula (I-12b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0185] In another particularly preferred group of compounds of formula (I-12b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; more preferably R 6is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl; even more preferably, R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0186] In a further particularly preferred group of compounds of formula (I-12b), R 6 is preferably cyanocyclopropyl; more preferably R 6 is 1-cyanocyclopropyl.
[0187] One preferred group of compounds according to this embodiment are compounds of formula (I-12c), which are compounds of formula (I-12) or any of the preferred embodiments of compounds of formula (I-12), wherein A is N.
[0188] Another preferred group of compounds according to this embodiment are compounds of formula (I-12e), which are compounds of formula (I-12) or any of the preferred embodiments of compounds of formula (I-12), wherein A is CH.
[0189] Another distinguishing group of compounds according to the invention is represented by formula (I-13): [ka] (In the formula, R 2 is as defined in formula I above, and Q is of the formula Qa1 and Qb1 [ka] where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A, R 5 and R 6 is as defined in formula I above. or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof; R 2 is preferably H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, C(O)R 3 or cyano; R 3 is C 1 ~C 4 alkyl; preferably, R 3 is methyl.
[0190] In a preferred group of compounds of formula I-13, A is N.
[0191] In another preferred group of compounds of formula I-13, R 2 H, cyano, COCH 3 , cyclopropyl, methyl, ethyl, trifluoroethyl or trifluoromethyl; more preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl.
[0192] In a particularly preferred group of compounds of formula I-13, R2 is H, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; even more preferably, R 2 is H or ethyl.
[0193] One preferred group of compounds according to this embodiment are compounds of formula (I-13a), which are compounds of formula (I-13) or any of the preferred embodiments of compounds of formula (I-13), wherein Q is Qa1.
[0194] Another preferred group of compounds according to this embodiment are compounds of formula (I-13b), which are compounds of formula (I-13) or any of the preferred embodiments of compounds of formula (I-13), wherein Q is Qb1.
[0195] In a preferred group of compounds of formula (I-13a), R 5 is preferably H; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0196] In a more preferred group of compounds of formula (I-13a), R 5 is preferably H; or R 5is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 haloalkyl; or R 5 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0197] In a particularly preferred group of compounds of formula (I-13a), R 5 is preferably H, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; even more preferably R 5 is selected from the group consisting of H, 3-chloro-pyrazol-1-yl, 3-trifluoromethyl-pyrazol-1-yl, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0198] In a distinct group of compounds of formula (I-13a), R 5 is preferably H, unsubstituted C-linked pyrimidinyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; more preferably R 5is selected from the group consisting of H, pyrimidin-2-yl, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl and 3-trifluoromethyl-1,2,4-triazol-1-yl; even more preferably, R 5 is selected from the group consisting of H, pyrimidin-2-yl, and 1,2,4-triazol-1-yl.
[0199] In a further distinct group of compounds of formula (I-13a), R 5 is preferably H or an N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl; more preferably R 5 is selected from the group consisting of H, 1,2,4-triazol-1-yl, 3-chloro-1,2,4-triazol-1-yl, and 3-trifluoromethyl-1,2,4-triazol-1-yl.
[0200] In a preferred group of compounds of formula (I-13b), R 6 is preferably C 3 ~C 6 Cycloalkyl, monosubstituted by cyano 3 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 (In the formula, R 7 and R 8 are mutually independent, C 1 ~C 4 alkyl), -N(R 9 )COR 10 (In the formula, R 9 and R 10 are mutually independent, C 1 ~C 4 alkyl) or 2-pyridyloxy; or R 6is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1 or 2 ring nitrogen atoms; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; and said ring system contains 1, 2 or 3 ring nitrogen atoms.
[0201] In a more preferred group of compounds of formula (I-13b), R 6 is preferably cyclopropyl, cyanocyclopropyl, C 1 ~C 4 Haloalkoxy, C substituted with cyano 1 ~C 4 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; most preferably, R 6 is cyclopropyl, cyanocyclopropyl, -OCH 2 CF 3 , -OCH 2 CF 2 CH 3 , C monosubstituted by cyano 1 ~C 3 Alkoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 or 2-pyridyloxy; or R 6is a 6-membered aromatic ring system selected from pyridyl and pyrimidinyl, attached via a ring carbon atom to a ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano and C 1 ~C 4 haloalkyl; or R 6 is a 5-membered aromatic ring system selected from pyrazolyl, imidazolyl and triazolyl, attached via a ring nitrogen atom to a ring containing the substituent A, said ring system being unsubstituted or containing halogen and C 1 ~C 4 It is monosubstituted with a substituent selected from the group consisting of haloalkyl.
[0202] In a particularly preferred group of compounds of formula (I-13b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, cyanoisopropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; even more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0203] In another particularly preferred group of compounds of formula (I-13b), R 6 is preferably cyclopropyl, cyanocyclopropyl, trifluoroethoxy, difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro, cyano or trifluoromethyl; more preferably R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl; even more preferably, R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 )COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl and 3-trifluoromethyl-pyrazol-1-yl.
[0204] In a further particularly preferred group of compounds of formula (I-13b), R 6 is preferably C-linked pyrimidinyl, which may be monosubstituted by cyanocyclopropyl, 2-pyridyloxy or cyano; more preferably R 6is 1-cyanocyclopropyl, 2-pyridyloxy or 5-cyano-pyrimidin-2-yl.
[0205] One preferred group of compounds according to this embodiment are compounds of formula (I-13c), which are compounds of formula (I-13) or any of the preferred embodiments of compounds of formula (I-13), wherein A is N.
[0206] Another preferred group of compounds according to this embodiment are compounds of formula (I-13e), which are compounds of formula (I-13) or any of the preferred embodiments of compounds of formula (I-13), wherein A is CH.
[0207] The compounds of the present invention may have any number of benefits, including, inter alia, advantageous levels of biological activity for protecting plants against insects or excellent properties for use as agrochemical active ingredients (e.g., high biological activity, advantageous activity spectrum, high safety profile, improved physicochemical properties, or high biodegradability or environmental profile).In particular, it has been unexpectedly found that certain compounds of formula (I) may exhibit advantageous safety profiles against non-target arthropods, particularly pollinators such as honeybees, solitary bees, and bumblebees.Most specifically, the Western honeybee (Apis mellifera).
[0208] In another aspect, the present invention provides a composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any of embodiments 1, 2 or 3 (above) or any of the embodiments relating to compounds of formula (I-1), (I-2), (I-3), (I-4), (I-5), (I-6), (I-7), (I-8), (I-9), (I-10), (I-11), (I-12) or (I-13) or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, and optionally an auxiliary or diluent.
[0209] In a further aspect, the present invention provides a method for combating and controlling insects, acaridae, nematodes or molluscs, comprising the step of applying to the pest, the pest's habitat or plants susceptible to attack by the pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any of embodiments 1, 2 or 3 (above) or in any of the embodiments of the compounds of formula (I-1), (I-2), (I-3), (I-4), (I-5), (I-6), (I-7), (I-8), (I-9), (I-10), (I-11), (I-12) or (I-13) (above) or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof or a composition as defined above.
[0210] In a further aspect, the present invention provides a method for protecting plant propagation material from attack by insects, acaridae, nematodes or mollusks, comprising the step of treating the propagation material or the locus in which the propagation material is planted with a composition as defined above.
[0211] The process according to the invention for preparing the compounds of formula I is carried out by methods known to those skilled in the art. 2 and R 1 , R 2 , R 4 , R 5 , G 1 , G 2 , G 3 and A are defined as in formula I above) can be represented by the formula I-a2, where X is SO and R 1 , R 2 , R 4 , R 5 , G 1 , G 2 , G 3and A can be prepared by oxidation of a compound of formula I, as defined above. The reaction can be carried out with a reagent such as a peracid, such as peracetic acid or m-chloroperbenzoic acid, or a hydroperoxide, such as hydrogen peroxide or tert-butyl-hydroperoxide, or an inorganic oxidizing agent, such as monoperoxodisulfate or potassium permanganate. Similarly, compounds of formula I-a2, where X is SO and R 1 , R 2 , R 4 , R 5 , G 1 , G 2 , G 3 and A are defined as in formula I above) can be prepared under similar conditions as above to obtain a compound of formula I-a1 (wherein X is S and R 1 , R 2 , R 4 , R 5 , G 1 , G 2 , G 3 and A can be prepared by oxidation of compounds of formula I defined above). These reactions can be carried out in a variety of organic or aqueous solvents compatible with these conditions at temperatures below 0° C. up to the boiling point of the solvent system. Examples of solvents used in the reactions include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, alcohols such as methanol and ethanol, acetic acid, water; and mixtures thereof. Compounds of formula I-a1 can also be directly oxidized to compounds of formula I-a3 under similar conditions as described above. The conversion of compounds of formula I-a1 to compounds of formula I-a2 and I-a3 is depicted in Scheme 1. Scheme 1 [ka]
[0212] Formula I-aa3 (Scheme 2) (wherein X is SO 2 and R 1 , R 2 , R 4 , R 6 , G 1 , G 2 , G 3and A are defined as in formula I above), can be prepared by a similar procedure as described in Scheme 1 for the synthesis of compounds of formula I-a3, from compounds of formula I-aa2 or formula I-aa1 (wherein X is SO 2 and R 1 , R 2 , R 4 , R 6 , G 1 , G 2 , G 3 and A may be prepared from a compound of formula I defined above. Scheme 2 [ka]
[0213] Alternatively, the compound of formula I-a5, 1 , G 1 , G 2 , G 3 and Q are defined above in formula I; R 2 Compounds of formula (I) can be prepared by the reaction of the compound with hypervalent iodine reagents, such as diacetoxyiodobenzene PhI(OAc). 2 in a solvent such as toluene, acetonitrile or an alcohol (preferably, inter alia, methanol, 2,2,2-trifluoroethanol or 2,2,3,3,4,4,5,5-octafluoropentan-1-ol) at a temperature between 0 and 100° C., preferably at about room temperature, for example in analogy with the description found in Chem. Commun. 2017, 53, 348-351 (and references cited therein), to form a compound of formula II (wherein R 1 , G 1 , G 2 , G 3 and Q can be prepared by reacting a sulfide compound of formula I above) with a suitable nitrogen source, such as ammonia, ammonium carbamate or ammonium acetate (preferably ammonium carbamate) (Scheme 3). Scheme 3 [ka] Alternatively, the compound of formula III, 1 , G 1 , G 2 , G 3 and Q are defined as in formula I above), can be reacted with, inter alia, sodium azide or trimethylsilyl azide in the presence of an acid catalyst, such as sulfuric acid, trifluoroacetic acid, methanesulfonic acid, Eaton's reagent, at temperatures between 0° C. and 100° C., in solvents, such as toluene, dichloromethane, chloroform, in other halogenated solvents, to give sulfoxide compounds of formula I-a5, where R 1 , G 1 , G 2 , G 3 and Q are defined above in formula I; R 2 is H. Such reactions are described, for example, in Org. Process Res. Dev. 2015, 19(8), 1062-1067 and in WO 16 / 180695.
[0214] Formula III (wherein, R 1 , G 1 , G 2 , G 3 and Q are defined as in formula I above) can be converted into sulfoxide compounds of formula II (wherein R 1 , G 1 , G 2 , G 3 and Q may be prepared by oxidation of a sulfide compound of formula I defined above.
[0215] Alternatively, the compound of formula I-a5, 1 , G 1 , G 2 , G 3 and Q are defined above in formula I; R 2 is H), a compound of formula IV (wherein R 1 , G 1 , G 2 , G 3 and Q are defined in formula I above, and Rn is CN, -C=O(C 1 ~C6 alkyl), -C=O(C 1 ~C 6 haloalkyl) or SO 2 -aryl) (Scheme 4). Scheme 4 [ka] For example, a compound of formula IV (wherein R 1 , G 1 , G 2 , G 3 and Q are defined as in formula I above and Rn is CN, can be converted to compounds of formula IV, where Rn is C(O)CF, by treatment with trifluoroacetic anhydride in a solvent such as dichloromethane, as described, for example, in O.G. Mancheno, C. Bolm, Org. Lett. 2007, 9, 3809-3811. 3 The compound of formula IV, wherein R 1 , G 1 , G 2 , G 3 and Q are defined above in formula I, and Rn is C(O)CF 3 Compounds of formula I-a5) can be converted to compounds of formula I-a6 by treatment with a base, such as sodium carbonate or potassium carbonate, in a polar protic solvent, such as methanol or ethanol, as described, for example, in H. Okamura, C. Bolm, Org. Lett. 2004, 6, 1305-1307.
[0216] Formula IV (wherein, R 1 , G 1 , G 2 , G 3 and Q are defined in formula I above, and Rn is CN, -C=O(C 1 ~C 6 alkyl), -C=O(C 1 ~C 6 haloalkyl) or SO 2 -aryl) has the formula RNH 2in which Rn is as defined above), in the presence of a reagent of formula III, in which Rn is as defined above, as described, for example, in H. Okamura, C. Bolm, Org. Lett. 2004, 6, 1305-1307; H. Okamura, C. Bolm, Chem. Lett. 2004, 33, 482-487; D. Leca, K. Song, M. Amatore, L. Fensterbank, E. Lacote, M. Malacria, Chem. Eur. J. 2004, 10, 906-916; or M. Reggelin, C. Zur, Synthesis, 2000, 1-64 1 , G 1 , G 2 , G 3 and Q can be prepared by subjecting a compound of formula I, as defined above, to imination reaction conditions. Alternative imination reagents / conditions include NaN 3 / H 2 SO 4 , O-mesitylenesulfonyl-hydroxylamine (MSH) or metal-catalyzed methods [see O. G. Mancheno, C. Bolm, Chem. Eur. J. 2007, 13, 6674-6681], e.g. R n -N 3 / FeCl 2 , R n -NH 2 / Fe(acac) 3 / PhI=O, PhI=NR n / Fe(OTf) 2 , PhI=NR n / CuOTf, PhI=NR n / Cu(OTf) 2 , PhI=NR n / CuPF 6 , PhI(OAc) 2 / R n -NH 2 / MgO / Rh 2 (OAc) 4 or oxaziridine (eg, 3-(4-cyano-phenyl)-oxaziridine-2-carboxylic acid tert-butyl ester).
[0217] Of particular interest are Rn-NH 2 and an oxidizing agent, such as PhI(OAc). 2 / Rn-NH 2 or N-bromosuccinimide (NBS) / Rn-NH as described in C. Bolm et al., Synthesis 2010, No 17, 2922-2925. 2 and a metal-free imination method involving a base, such as sodium or potassium tert-butoxide. Oxidizing agents, such as N-iodosuccinimide (NIS) or iodine, may alternatively be used, as described, for example, in OG Mancheno, C. Bolm, Org. Lett. 2007, 9, 3809-3811. Examples of hypochlorites used as oxidizing agents include sodium hypochlorite NaOCl or calcium hypochlorite Ca(OCl). 2 was described in WO 2008 / 1060.
[0218] Formula III (wherein, R 1 , G 1 , G 2 , G 3 and Q are defined as in formula I above), can be prepared by reacting a compound of formula II, 1 , G 1 , G 2 , G 3 and Q can be prepared from a compound of formula I defined above.
[0219] Conversely, the order of the two oxidation / imination steps can be reversed as shown in Scheme 5. Scheme 5 [ka]
[0220] Thus, compounds of formula IV can be prepared from compounds of formula V by oxidation, by involving the same chemical reactions as described above in Scheme 4; compounds of formula V can be prepared from compounds of formula II by imination.
[0221] Alternatively, the compound of formula I-a6, 1 , R 2 , G 1 , G 2 , G 3 and Q are defined as in formula I above) can be represented by the formula I-a5, 1 , G 1 , G 2 , G 3 and Q are defined above in formula I; R 2 is H) and a reagent R 2 -X 0 (In the formula, R 2 is as defined in formula I above, and X 0 can be prepared by alkylation or metal-catalyzed coupling with a leaving group such as a halide, for example chloro, bromo or iodo, or an aryl or alkyl sulfonate, for example trifluoromethanesulfonate (Scheme 6). Scheme 6 [ka] The alkylation reaction can be carried out in the presence of a base, such as sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, cesium carbonate, triethylamine, among others, in the presence of a solvent, such as dichloromethane, dichloroethane, DMF, DMSO, ethanol, methanol, among others, at a temperature between 0° C. and the boiling point of the solvent. Metal-catalyzed coupling for the preparation of compounds of formula I-a6 from compounds of formula I-a5 can be carried out in the presence of a base, such as potassium carbonate, cesium carbonate, sodium hydroxide, in an inert solvent, such as toluene, dimethyl-formamide DMF, N-methylpyrrolidine NMP, dimethylsulfoxide DMSO, dioxane, tetrahydrofuran THF, and the like, optionally with a catalyst, such as palladium(II) acetate, bis(dibenzylideneacetone)palladium(0) (Pd(dba) 2 ) or tris(dibenzylideneacetone)dipalladium(0) (Pd 2 (dba) 3 , optionally in the form of a chloroform adduct) or in the presence of a palladium precatalyst, such as tert-BuBrettPhos Pd G3 [(2-di-tert-butylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate or BrettPhos Pd G3 [(2-di-cyclohexylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate, optionally in the presence of a ligand, such as SPhos, t-BuBrettPhos or XantPhos, at a temperature of 60 to 120°C, optionally under microwave irradiation.
[0222] Formula I-a6 (wherein, R 1 , G 1 , G 2 , G 3 and Q are defined above in formula I; R 2 is -C(O)R 3 and R 3 is C 1 ~C 6The compound of formula LG-1, optionally in the presence of an acylation catalyst such as 4-dimethylaminopyridine (DMAP), preferably in the presence of a base such as triethylamine, diisopropylethylamine or pyridine, can be reacted with the compound of formula LG-1 at a temperature of 0-50° C. in an inert solvent. 1 -C(O)R 3 Reagent of formula R 3 C(O)-OC(O)R 3 Anhydrous reagent (wherein R 3 is C 1 ~C 6 Alkyl, LG 1 is a leaving group, such as a halogen (especially chlorine), to give compounds of formula I-a5, 1 , G 1 , G 2 , G 3 and Q are defined in formula I above). Examples of solvents used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethylsulfoxide. The reaction may be carried out in the presence of an excess of base (which may then also act as a solvent or excipient). Such conditions are described, for example, in WO 15 / 071180.
[0223] Formula II (wherein, R 1 , G 1 , G 2 , G 3 and Q are defined as in formula I above), can be prepared by, for example, reacting acetic acid or trifluoroacetic acid (preferably G 3 is NMe), to form a compound of formula (VI) 1 , G 1 , G 2 , G 3and Q may be prepared by cyclization of a compound of formula I defined above (Scheme 7). Scheme 7 [ka] Formula (VI) (wherein, R 1 , G 1 , G 2 , G 3 Cyclization of a compound of formula (VI) may also be accomplished in the presence of an acid catalyst, such as methanesulfonic acid or para-toluenesulfonic acid p-TsOH, in an inert solvent, such as N-methylpyrrolidone, toluene or xylene, at temperatures between 25 and 180° C., preferably between 100 and 170° C. Such processes have been previously described, for example in WO 2010 / 125985. Alternatively, a compound of formula (VI) may be cyclized to a compound of formula II (preferably G) using triphenylphosphine, diisopropyl azodicarboxylate (or diethyl azodicarboxylate) in an inert solvent, such as tetrahydrofuran THF, at temperatures between 20 and 50° C. 3 is O. Such Mitsunobu conditions have been previously described for these conversions (see WO 2009 / 131237).
[0224] Formula (VI) (wherein, R 1 , G 1 , G 2 , G 3 and Q are as defined in formula I) can be prepared by i) activation of a compound of formula (IX) (wherein Q is as defined in formula I) via acylation to give an activated species (VIII) (wherein Q is as defined in formula I and X) by methods known to those skilled in the art and described, for example, in Tetrahedron, 2005, 61(46), 10827-10852. 00 is a halogen, preferably chlorine). For example, compound (VIII) (X 00is a halogen, preferably chlorine), in the presence of a catalytic amount of N,N-dimethylformamide (DMF) in an inert solvent, such as methylene chloride (CH 2 Cl 2 or in tetrahydrofuran (THF) at a temperature of 20 to 100°C, preferably 25°C, for example, oxalyl chloride (COCl) 2 or thionyl chloride SOCl 2 Alternatively, treatment of a compound of formula (IX) with, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide EDC or dicyclohexylcarbodiimide DCC in an inert solvent, for example pyridine or tetrahydrofuran THF, optionally in the presence of a base, for example triethylamine, at a temperature of 50 to 180° C., gives the activated species (VIII), where X 00 are X 01 Or X 02 ), followed by ii) reacting a compound of formula (VII), in the presence of a base such as triethylamine, N,N-diisopropyl-ethyl-amine or pyridine, in an inert solvent such as dichloromethane, tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, ethyl acetate or toluene at a temperature of 0 to 50° C. 1 , G 1 , G 2 and G 3 is as defined in formula I) to form a compound of formula (VI).
[0225] Formula (VII) (wherein, R 1 , G 1 , G 2 and G 3 Compounds of formula I) are known, commercially available, or can be prepared by methods known to those skilled in the art.
[0226] Alternatively, the compound of formula I-a6, 1 , R 2 , G 1 , G 2, G 3 and Q are as defined in formula I above) can be prepared according to Scheme 8, similar to the procedures as described in Scheme 7. All substituent definitions previously stated remain valid. Scheme 8 [ka]
[0227] Formula XI (where R 1 , R 2 , G 1 , G 2 and G 3 Compounds of formula (I) (wherein R is as defined above in formula I) may be prepared according to Scheme 9. Scheme 9 [ka] Formula VII (wherein, R 1 , G 1 , G 2 and G 3 is as defined in formula I above) is a compound of formula PG-X 0 where PG is benzyl, para-methoxybenzyl, benzoyl, acetyl or tert-butyloxycarbonyl or similar other suitable protecting groups for NH or OH functions known to those skilled in the art, and X 0 is reacted with a leaving group, such as a halide, e.g., chloro, bromo, or iodo, or an aryl or alkyl sulfonate, e.g., trifluoromethanesulfonate, to give a compound of formula XIII, 1 , G 1 , G 2 and G 3is as defined in formula I, PG is benzyl, para-methoxybenzyl, benzoyl, acetyl or tert-butyloxycarbonyl or similar other suitable protecting group for NH or OH functional groups, and n is 1 or 2. Compounds of formula XIII can be prepared by applying the chemical reactions and conditions described in Schemes 3 and 4 and Scheme 6 to form compounds of formula XV, where R 1 , R 2 , G 1 , G 2 and G 3 is as defined in formula I, PG is benzyl, para-methoxybenzyl, benzoyl, acetyl or tert-butyloxycarbonyl or similar other suitable protecting group for NH or OH functional group, and n is 1 or 2. Compounds of formula XV can be converted to compounds of formula XI, where R 1 , R 2 , G 1 , G 2 and G 3 is as defined above in formula I. In one example, PG can be converted to a compound of formula XV by -CO 2 When it is a t-Bu group, this can be deprotected using an acid such as trifluoroacetic acid, hydrochloric acid, sulfuric acid, among others, to form a compound of formula XI.
[0228] Certain compounds of formula IX (wherein Q is as defined in formula I above) are commercially available. Other compounds of formula IX (wherein Q is as defined in formula I above) are known in the literature (e.g., compounds Q-1 to Q-10 below), for example the synthesis of Q-1 (X is S) in WO 18 / 108726, the synthesis of Q-2 in WO 16 / 046071, and the synthesis of Q-3 in WO 17 / 146226. [ka]
[0229] Other compounds of formula IX can be prepared by one skilled in the art in analogy to the methods described for the synthesis of compounds Q-1 to Q-10 ("CAS" means Chemical Abstracts Registry Number). [ka]
[0230] Formula I (wherein, R 1 , R 2 , G 1 , G 2 , G 3 is as defined in formula I above, Q is defined as Qb, A, X, R 4 and R 6 A subgroup of compounds of formula I-Qb (wherein R is as defined in formula I) may be defined as compounds of formula I-Qb (Scheme 10).
[0231] In certain circumstances in Scheme 10, R 6 is an optionally substituted triazole attached via a ring nitrogen atom to the ring containing the group A, the formula I-Qb (wherein X is SO or SO 2 The compound of formula (I) is preferably prepared by the addition of a base such as potassium carbonate K in a solvent such as an alcohol (e.g., methanol, ethanol, isopropanol or a high-boiling linear or branched alcohol), pyridine or acetic acid. 2 CO 3 or Cesium Carbonate Cs 2 CO 3 in the presence of optionally a copper catalyst, such as copper(I) iodide, at a temperature of 30 to 180° C., optionally under microwave irradiation, 6 -H (containing a suitable NH functionality) (XVIIaa) (wherein R 6 is an N-linked triazolyl) (CN bond formation) to give the compound of formula XVIb, 1 , R 2 , G 1 , G 2 , G 3 , A and R4 is as defined in formula I above, and X is SO or SO 2 and X b can be prepared from a compound having a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine) or an aryl or alkyl sulfonate, such as trifluoromethanesulfonate. Scheme 10 [ka]
[0232] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh 3 ) 4 ) or Pd(dppf)Cl 2 ), bases (e.g., Na 2 CO 3 ), solvent (e.g., 1,2-dimethoxyethane / water), 25 to 180°C. (b) Stille reaction: Pd catalyst (e.g., Pd(PPh 3 ) 4 ) or Pd(PPh 3 )Cl 2 ), solvent (e.g., toluene), 25 to 180°C. (c) C-N bond formation: any base (e.g., K 2 CO 3 Or Cs 2 CO 3 ), optionally in the presence of a copper or palladium catalyst, optionally in the presence of an additive (e.g., N,N'-dimethylethylenediamine), optionally in the presence of a ligand (e.g., Xantphos), a solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), at 25 to 180°C.
[0233] Alternatively, the compound of formula I-Qb, where X is SO or SO 2 The compound of formula XVIb, 1 , R 2 , G 1 , G 2 , G 3 , A and R 4is as defined in formula I above, and X is SO or SO 2 and Xb is a leaving group, such as chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, such as trifluoromethanesulfonate, with a compound of formula (XVII) 6 is as defined in formula I; Y b1 is a boron-derived functional group, e.g., B(OH) 2 OR B b1 ) 2 R b1 is C 1 ~C 4 It may be an alkyl group or may contain two groups OR b1 can be prepared by Suzuki reaction, which involves reacting a compound of (which together with the boron atom can form a five-membered ring, for example as a pinacolboronic acid ester). The reaction can be catalyzed by a palladium-based catalyst, for example tetrakis(triphenyl-phosphine)palladium(0), (1,1'bis(diphenylphosphino)ferrocene)dichloro-palladium-dichloromethane (1:1 complex) or chloro(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (XPhos palladacycle), in a solvent or solvent mixture, for example dioxane, acetonitrile, N,N-dimethyl-formamide, a mixture of 1,2-dimethoxyethane and water, or a mixture of dioxane / water, or a mixture of toluene / water, preferably under an inert atmosphere, in the presence of a base, for example sodium carbonate, tripotassium phosphate or cesium fluoride. The reaction temperature may preferentially range from room temperature to the boiling point of the reaction mixture, or the reaction may be carried out under microwave irradiation. Such Suzuki reactions are well known to those skilled in the art and are reviewed, for example, in J. Orgmet. Chem. 576, 1999, 147-168.
[0234] Alternatively, the compound of formula I-Qb, where X is SO or SO 2 The compound of formula (XVIIa),6 is as defined above, and Y b2 is a trialkyltin derivative, preferably tri-n-butyltin or tri-methyltin, and a compound of formula XVIb, where R 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is SO or SO 2 and Xb can be prepared by a Stille reaction between compounds of leaving groups such as chlorine, bromine or iodine (preferably chlorine or bromine) or arylsulfonates or alkylsulfonates, such as trifluoromethanesulfonate. Such Stille reactions are usually carried out in the presence of a palladium catalyst, such as tetrakis(triphenylphosphine)palladium(0) or bis(triphenylphosphine)palladium(II) dichloride, in an inert solvent, such as N,N-dimethylformamide, acetonitrile, toluene or dioxane, optionally in the presence of an additive, such as cesium fluoride or lithium chloride, and optionally in the presence of a further catalyst, such as copper(I) iodide. Such Stille couplings are also well known to those skilled in the art and are described, for example, in J. Org. Chem., 2005, 70, 8601-8604, J. Org. Chem., 2009, 74, 5599-5602 and Angew. Chem. Int. Ed., 2004, 43, 1132-1136.
[0235] R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to the ring containing the substituent A, the formula I-Qb (wherein X is SO or SO 2 The compound of formula (I) can be reacted with a base, e.g. potassium carbonate, K 2 CO 3 or Cesium Carbonate Cs 2 CO 3in the presence of optionally a copper catalyst, such as copper(I) iodide, with or without an additive, such as L-proline, N,N'-dimethylcyclohexane-1,2-diamine or N,N'-dimethyl-ethylene-diamine, in an inert solvent, such as N-methylpyrrolidone NMP or N,N-dimethylformamide DMF, at a temperature between 30 and 150°C, optionally under microwave irradiation, to form the heterocycle R 6 -H (containing a suitable NH functionality) (XVIIaa) (wherein R 6 is as defined above) to give a compound of formula XVIb, 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is SO or SO 2 and Xb can be prepared from a compound having a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, such as trifluoromethanesulfonate.
[0236] In certain circumstances in Scheme 10, R 6 -N(R 9 )C(=O)R 10 (In the formula, R 9 and R 10 is as defined in formula I, then formula I-Qb (wherein X is SO or SO 2 The compound HN(R 9 )COR 10 (In the formula, R 9 and R 10 is as defined in formula I) 6 -H(XVIIaa) (CN bond formation) to give 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is SO or SO 2and Xb is a leaving group, such as chlorine, bromine or iodine (preferably chlorine or bromine) or an aryl or alkyl sulfonate, such as trifluoromethanesulfonate. Such reactions can be carried out in the presence of a base, such as potassium carbonate, cesium carbonate, sodium hydroxide, in an inert solvent, such as toluene, dimethylformamide DMF, N-methylpyrrolidine NMP, dimethylsulfoxide DMSO, dioxane, tetrahydrofuran THF, etc., optionally with, for example, palladium(II) acetate, bis(dibenzylideneacetone)palladium(0) (Pd(dba) 2 ) or tris(dibenzylideneacetone)dipalladium(0) (Pd 2 (dba) 3 , optionally in the form of the chloroform adduct) or a palladium precatalyst, such as for example t-BuBrettPhos Pd G3[(2-di-t-butylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate or BrettPhos Pd G3[(2-di-cyclohexylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate, and optionally in the presence of a ligand, such as for example SPhos, t-BuBrettPhos or XantPhos, at a temperature between 60 and 120°C, optionally under microwave irradiation.
[0237] In certain circumstances in Scheme 10, R 6 N(R 11 )R 12 (In the formula, R 11 , R 12 is as defined in formula I, then formula I-Qb (wherein X is SO or SO 2 The compound HN(R 11 )R 12or a salt thereof (e.g., a hydrohalide, preferably a hydrochloride, or a hydrobromide, or a trifluoroacetate, or any other equivalent salt), 11 , R 12 is as defined in formula I) 6 -H(XVIIaa) (CN bond formation) to give 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is SO or SO 2 and Xb can be prepared from a compound having a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, such as trifluoromethanesulfonate. Such reactions are usually carried out in inert solvents such as alcohols, amides, esters, ethers, nitriles and water, particularly preferably methanol, ethanol, 2,2,2-trifluoroethanol, propanol, isopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, toluene, water or mixtures thereof, at temperatures between 0 and 150° C., optionally under microwave irradiation or under pressure in an autoclave, optionally in the presence of a copper catalyst such as copper powder, copper(I) iodide or copper sulfate (optionally in the form of a hydrate) or mixtures thereof, optionally in the presence of a ligand such as, for example, a diamine ligand (for example, N,N′-dimethylethylenediamine or trans-cyclohexyldiamine), or dibenzylideneacetone (dba), or 1,10-phenanthroline, and optionally in the presence of a base such as potassium phosphate.
[0238] Reagent HN(R 11 )R 12 and HN(R 9 )C(=O)R 10 (In the formula, R 9 , R 10 , R 11and R 12 is as defined in formula I), are known, commercially available, or can be prepared by methods known to those skilled in the art.
[0239] In certain circumstances in Scheme 10, R 6 -N=S(O)R 7 R 8 (In the formula, R 7 and R 8 is as defined in formula I, then formula I-Qb (wherein X is SO or SO 2 The compound HN=S(O)R 7 R 8 (In the formula, R 7 and R 8 is as defined in formula I) 6 -H(XVIIaa) (CN bond formation) to give 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is SO or SO 2 and Xb can be prepared from a compound having a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, such as trifluoromethanesulfonate. Such reactions can be carried out, for example, analogously to the description found in WO 18099812.
[0240] Reagent HN=S(O)R 7 R 8 (In the formula, R 7 and R 8 is as defined in formula I), are known, commercially available, or can be prepared by methods known to those skilled in the art.
[0241] Formula XVIb (wherein X is SO or SO 2 by oxidation of a compound of formula XVIb, 1, R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, X is S and Xb is a leaving group, such as chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, such as trifluoromethanesulfonate, may be achieved under the conditions already described above.
[0242] Many compounds of formula (XVII), (XVIIa) and (XVIIaa) are commercially available or can be prepared by one skilled in the art.
[0243] Alternatively, the compound of formula I-Qb, where X is SO or SO 2 Compounds of formula XVIb (wherein X is S (sulfide)) can be prepared from compounds of formula XVIb (wherein X is S) by the same chemical reactions as described above but by changing the order of steps (i.e., carrying out the sequence from XVIb (X is S) to I-Qb (X is S) via Suzuki, Stille or CN bond formation followed by an oxidation step to I-Qb (X is SO or SO 2 The compound can be prepared by forming
[0244] Formula XVIb (where R 1 , R 2 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is S, SO or SO 2 and X b is a leaving group, for example chlorine, bromine or iodine (preferably chlorine or bromine) or an arylsulfonate or alkylsulfonate, for example trifluoromethanesulfonate, can be prepared according to the chemical reactions already disclosed in Scheme 6 by the addition of a compound of formula XVIIIb, where R 1 , G 1 , G 2 , G 3 , A and R4 is as defined in formula I above, and X is S, SO or SO 2 and X b can be prepared from compounds which have a leaving group such as chlorine, bromine or iodine (preferably chlorine or bromine) or an aryl or alkyl sulfonate, such as trifluoromethanesulfonate (Scheme 10a). Scheme 10a [ka]
[0245] Formula XVIIIb (wherein, R 1 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, and X is S, SO or SO 2 and X b is a leaving group, e.g., chlorine, bromine or iodine (preferably chlorine or bromine) or an aryl or alkyl sulfonate, e.g., trifluoromethanesulfonate, can be converted to a compound of formula II-X by applying the chemical reactions already disclosed in Scheme 3 and the oxidation conditions described above. b (In the formula, R 1 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, X is S, and X b is a leaving group as defined above.
[0246] Formula II-X b (In the formula, R 1 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, X is S, and X bis a leaving group as defined above), compounds of formulae VI-X can be obtained by following the chemical reactions already disclosed in Scheme 7. b (In the formula, R 1 , G 1 , G 2 , G 3 , A and R 4 is as defined in formula I above, X is S, and X b is a leaving group as defined above), b (Wherein, A and R 4 is as defined in formula I above, X is S, and X b is a leaving group as defined above) and a compound of formula VII, 1 , G 1 , G 2 and G 3 can be prepared from a compound of formula I, which is defined above.
[0247] Formula IX-X b (Wherein, A and R 4 is as defined in formula I above, X is S, and X b is a leaving group, such as chlorine, bromine or iodine (preferably chlorine or bromine), are known (see, for example, Q-4 discussed above), commercially available, or can be prepared by methods known to those skilled in the art.
[0248] Formula I (wherein, R 1 , R 2 , G 1 , G 2 , G 3 is as defined in formula I above, Q is defined as Qa, A, X, R 4 and R 5 A subgroup of compounds of formula I-Qa (wherein R is as defined in formula I) may be defined as compounds of formula I-Qa (Scheme 11). Scheme 11 [ka]
[0249] (a) Suzuki reaction: Pd catalyst (e.g., Pd(PPh 3 ) 4 ) or Pd(dppf)Cl 2 ), bases (e.g., Na 2 CO 3 ), solvent (e.g., 1,2-dimethoxyethane / water), 25 to 180°C. (b) Stille reaction: Pd catalyst (e.g., Pd(PPh 3 ) 4 ) or Pd(PPh 3 )Cl 2 ), solvent (e.g., toluene), 25 to 180°C. (c) C-N bond formation: any base (e.g., K 2 CO 3 Or Cs 2 CO 3 ), optionally in the presence of a copper or palladium catalyst, optionally in the presence of an additive (e.g., N,N'-dimethylethylenediamine), optionally in the presence of a ligand (e.g., Xantphos), a solvent (e.g., dioxane, pyridine or N,N-dimethylformamide DMF), at 25 to 180°C.
[0250] The chemical reactions previously described in Scheme 10 for accessing compounds of formula I-Qb from compounds of formula XVIb can be applied analogously for the preparation of compounds of formula I-Qa from compounds of formula XVIa (Scheme 11), where all the previously described substituent definitions remain valid.
[0251] The reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamides, alkylenediamides, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).
[0252] The reactants can be reacted with each other as is, i.e. without adding a solvent or diluent. However, in most cases, it is advantageous to add an inert solvent or diluent or a mixture thereof. When the reaction is carried out in the presence of a base, the base used in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, can also serve as a solvent or diluent.
[0253] The reaction is advantageously carried out at a temperature in the range of about -80°C to about +140°C, preferably about -30°C to about +100°C, and in many cases in the range of ambient temperature to about +80°C.
[0254] In conventional manner, compounds of formula I can be converted into other compounds of formula I in a manner known per se, by replacing one or more of the substituents of the starting compound of formula I by other substituents according to the invention, and by subsequent modification of the compound by reactions such as oxidation, alkylation, reduction, acylation and other methods known to those skilled in the art.
[0255] Depending on the respective suitable reaction conditions and the choice of starting materials, it is possible, for example, to simply replace one substituent with another substituent according to the invention in one reaction step, or several substituents may be replaced with other substituents according to the invention in the same reaction step.
[0256] Salts of compounds of formula I can be prepared in a manner known per se: thus, for example, acid addition salts of compounds of formula I can be obtained by treatment with a suitable acid or with a suitable ion exchange reagent, and base salts can be obtained by treatment with a suitable base or with a suitable ion exchange reagent.
[0257] The salts of the compounds of formula I can be converted in a customary manner into acid addition salts of the free compounds I, for example by treatment with suitable basic compounds or with suitable ion exchange reagents, and into salts with bases, for example by treatment with a suitable acid or with a suitable ion exchange reagent.
[0258] Salts of compounds of formula I may be converted into other salts, such as acid addition salts, of compounds of formula I in a manner known per se, for example by treating the inorganic acid salt, such as the hydrochloride, with a suitable metal salt, such as the sodium, barium or silver salt of the acid, for example silver acetate, in a suitable solvent in which the inorganic salt that forms silver chloride is insoluble and therefore precipitates from the reaction mixture.
[0259] Depending on the procedure or reaction conditions, compounds of formula I having salt-forming properties may be obtained in free form or in salt form.
[0260] The compounds of formula I and, where appropriate, their tautomers, in each free or salt form, can exist in the form of one of the possible isomers or as mixtures thereof, in the form of pure isomers, such as for example enantiomers and / or diastereomers, or as isomeric mixtures, such as enantiomeric mixtures, for example racemates, diastereomeric mixtures or racemic mixtures, depending on the number, the absolute and relative configuration of asymmetric carbon atoms occurring in the molecule and / or depending on the configuration of non-aromatic double bonds occurring in the molecule; the invention relates to the pure isomers and also to all possible isomeric mixtures, and is to be understood in this sense above and below, respectively, even if details of the stereochemistry are not specifically stated in each case.
[0261] Diastereomeric or racemic mixtures of compounds of formula I, in free or salt form, obtained depending on which starting materials and procedures are selected, may be separated in known manner into pure diastereomers or racemates on the basis of the physical chemical differences of the components, for example, by fractional crystallization, distillation and / or chromatography.
[0262] Enantiomeric mixtures, such as racemates, obtained in a similar manner can be resolved into their optical antipodes by known methods, for example by recrystallization from optically active solvents, by chromatography on chiral adsorbents, for example by high performance liquid chromatography (HPLC) on acetylcellulose using suitable microorganisms, by cleavage with specific immobilized enzymes via the formation of inclusion compounds, for example with chiral crown ethers, whereby only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting the basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphoric acid, tartaric acid or malic acid, or a sulfonic acid, for example camphorsulfonic acid, and separating the diastereomeric mixtures thus obtained, for example by fractional crystallization based on different solubilities, to obtain diastereomers from which the desired enantiomer can be released, by the action of a suitable substance, for example a basic substance.
[0263] Pure diastereomers or enantiomers can be obtained according to the invention not only by separating the appropriate isomeric mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, e.g. by carrying out the process according to the invention using starting materials that have stereochemical characteristics.
[0264] The N-oxide can be prepared by reacting a compound of formula I with a suitable oxidizing agent, e.g., H in the presence of an acid anhydride, e.g., trifluoroacetic anhydride. 2 O 2 / urea adduct. Such oxidations are known from the literature, for example from J. Med. Chem., 32(12), 2561-73, 1989 or WO 2000 / 15615.
[0265] When the individual components have different biological activities, it may be advantageous to isolate or synthesize the respective more biologically active isomer, e.g., enantiomer or diastereomer, or mixture of isomers, e.g., mixture of enantiomers or diastereomers.
[0266] The compounds of formula I and, where appropriate, their tautomers may each be obtained in free form or in the form of a salt, where appropriate, a hydrate, and / or may contain other solvents, such as solvents that may have been used for the crystallization of the compounds present in solid form.
[0267] The compounds according to the following Tables A-1 to A-96, C-1 to C-96, E-1 to E-96, F-1 to F-96, G-1 to G-96 and H-1 to H-96 can be prepared according to the above method. The following examples are intended to illustrate the present invention and show preferred compounds of formula I.
[0268] The following Tables A-1 to A-96 show specific compounds of the present invention.
[0269] "cPr" stands for cyclopropyl. [ka]
[0270] Table A-1 provides 14 compounds A-1.001 to A-1.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is N, X is S, and R 6 is as defined in Table B.
[0271] [Table 1]
[0272] Table A-2 provides 14 compounds A-2.001 to A-2.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0273] Table A-3 provides 14 compounds A-3.001 to A-3.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0274] Table A-4 provides 14 compounds A-4.001 to A-4.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0275] Table A-5 provides 14 compounds A-5.001 to A-5.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0276] Table A-6 provides 14 compounds A-6.001 to A-6.014 of formula I-1-Qb, where R 1 is Me and R 2 is H, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0277] Table A-7 provides 14 compounds A-7.001 to A-7.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0278] Table A-8 provides 14 compounds A-8.001 to A-8.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is N, X is SO, and R 6 is as defined in Table B.
[0279] Table A-9 provides 14 compounds A-9.001 to A-9.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0280] Table A-10 provides 14 compounds A-10.001 to A-10.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0281] Table A-11 provides 14 compounds A-11.001 to A-11.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is CH, X is SO, and R 6 is as defined in Table B.
[0282] Table A-12 provides 14 compounds A-12.001 to A-12.014 of formula I-1-Qb, where R 1 is Me and R 2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0283] Table A-13 provides 14 compounds A-13.001 to A-13.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is S, and R 6 is as defined in Table B.
[0284] Table A-14 provides 14 compounds A-14.001 to A-14.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0285] Table A-15 provides 14 compounds A-15.001 to A-15.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0286] Table A-16 provides 14 compounds A-16.001 to A-16.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0287] Table A-17 provides 14 compounds A-17.001 to A-17.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0288] Table A-18 provides 14 compounds A-18.001 to A-18.014 of formula I-1-Qb, where R 1 is Me and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0289] Table A-19 provides 14 compounds A-19.001 to A-19.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is N, X is S, and R 6 is as defined in Table B.
[0290] Table A-20 provides 14 compounds A-20.001 to A-20.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0291] Table A-21 provides 14 compounds A-21.001 to A-21.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0292] Table A-22 provides 14 compounds A-22.001 to A-22.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is S, and R 6 is as defined in Table B.
[0293] Table A-23 provides 14 compounds A-23.001 to A-23.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0294] Table A-24 provides 14 compounds A-24.001 to A-24.014 of formula I-1-Qb, where R 1 is Me and R 2 is cPr, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0295] Table A-25 provides 14 compounds A-25.001 to A-25.014 of formula I-1-Qb, where R 1 is Me and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0296] Table A-26 provides 14 compounds A-26.001 to A-26.014 of formula I-1-Qb, where R 1is Me and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0297] Table A-27 provides 14 compounds A-27.001 to A-27.014 of formula I-1-Qb, where R 1 is Me and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0298] Table A-28 provides 14 compounds A-28.001 to A-28.014 of formula I-1-Qb, where R 1 is Me and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0299] Table A-29 provides 14 compounds A-29.001 to A-29.014 of formula I-1-Qb, where R 1 is Me and R 2 is Me, A is CH, X is SO, and R 6 is as defined in Table B.
[0300] Table A-30 provides 14 compounds A-30.001 to A-30.014 of formula I-1-Qb, where R 1 is Me and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0301] Table A-31 provides 14 compounds A-31.001 to A-31.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is N, X is S, and R 6is as defined in Table B.
[0302] Table A-32 provides 14 compounds A-32.001 to A-32.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0303] Table A-33 provides 14 compounds A-33.001 to A-33.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0304] Table A-34 provides 14 compounds A-34.001 to A-34.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is CH, X is S, and R 6 is as defined in Table B.
[0305] Table A-35 provides 14 compounds A-35.001 to A-35.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0306] Table A-36 provides 14 compounds A-36.001 to A-36.014 of formula I-1-Qb, where R 1 is Me and R 2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0307] Table A-37 provides 14 compounds A-37.001 to A-37.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0308] Table A-38 provides 14 compounds A-38.001 to A-38.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0309] Table A-39 provides 14 compounds A-39.001 to A-39.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0310] Table A-40 provides 14 compounds A-40.001 to A-40.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0311] Table A-41 provides 14 compounds A-41.001 to A-41.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6is as defined in Table B.
[0312] Table A-42 provides 14 compounds A-42.001 to A-42.014 of formula I-1-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0313] Table A-43 provides 14 compounds A-43.001 to A-43.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0314] Table A-44 provides 14 compounds A-44.001 to A-44.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0315] Table A-45 provides 14 compounds A-45.001 to A-45.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0316] Table A-46 provides 14 compounds A-46.001 to A-46.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is S, and R6 is as defined in Table B.
[0317] Table A-47 provides 14 compounds A-47.001 to A-47.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0318] Table A-48 provides 14 compounds A-48.001 to A-48.014 of formula I-1-Qb, where R 1 is Me and R 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0319] Table A-49 provides 14 compounds A-49.001 to A-49.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is N, X is S, and R 6 is as defined in Table B.
[0320] Table A-50 provides 14 compounds A-50.001 to A-50.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0321] Table A-51 provides 14 compounds A-51.001 to A-51.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is N, and X is SO 2 and R6 is as defined in Table B.
[0322] Table A-52 provides 14 compounds A-52.001 to A-52.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0323] Table A-53 provides 14 compounds A-53.001 to A-53.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0324] Table A-54 provides 14 compounds A-54.001 to A-54.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is H, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0325] Table A-55 provides 14 compounds A-55.001 to A-55.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0326] Table A-56 provides 14 compounds A-56.001 to A-56.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is SO, and R 6is as defined in Table B.
[0327] Table A-57 provides 14 compounds A-57.001 to A-57.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0328] Table A-58 provides 14 compounds A-58.001 to A-58.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0329] Table A-59 provides 14 compounds A-59.001 to A-59.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is SO, and R 6 is as defined in Table B.
[0330] Table A-60 provides 14 compounds A-60.001 to A-60.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0331] Table A-61 provides 14 compounds A-61.001 to A-61.014 of formula I-1-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is S, and R6 is as defined in Table B.
[0332] Table A-62 provides 14 compounds A-62.001 to A-62.014 of formula I-1-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0333] Table A-63 provides 14 compounds A-63.001 to A-63.014 of formula I-1-Qb, where R 1 CF 3 and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0334] Table A-64 provides 14 compounds A-64.001 to A-64.014 of formula I-1-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0335] Table A-65 provides 14 compounds A-65.001 to A-65.014 of formula I-1-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0336] Table A-66 provides 14 compounds A-66.001 to A-66.014 of formula I-1-Qb, where R 1 CF 3and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0337] Table A-67 provides 14 compounds A-67.001 to A-67.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is S, and R 6 is as defined in Table B.
[0338] Table A-68 provides 14 compounds A-68.001 to A-68.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0339] Table A-69 provides 14 compounds A-69.001 to A-69.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0340] Table A-70 provides 14 compounds A-70.001 to A-70.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, X is S, and R 6 is as defined in Table B.
[0341] Table A-71 provides 14 compounds A-71.001 to A-71.014 of formula I-1-Qb, where R 1CF 3 and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0342] Table A-72 provides 14 compounds A-72.001 to A-72.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0343] Table A-73 provides 14 compounds A-73.001 to A-73.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0344] Table A-74 provides 14 compounds A-74.001 to A-74.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0345] Table A-75 provides 14 compounds A-75.001 to A-75.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0346] Table A-76 provides 14 compounds A-76.001 to A-76.014 of formula I-1-Qb, where R 1CF 3 and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0347] Table A-77 provides 14 compounds A-77.001 to A-77.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Me, A is CH, X is SO, and R 6 is as defined in Table B.
[0348] Table A-78 provides 14 compounds A-78.001 to A-78.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0349] Table A-79 provides 14 compounds A-79.001 to A-79.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Et, A is N, X is S, and R 6 is as defined in Table B.
[0350] Table A-80 provides 14 compounds A-80.001 to A-80.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0351] Table A-81 provides 14 compounds A-81.001 to A-81.014 of formula I-1-Qb, where R 1 CF 3and R 2 is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0352] Table A-82 provides 14 compounds A-82.001 to A-82.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is S, and R 6 is as defined in Table B.
[0353] Table A-83 provides 14 compounds A-83.001 to A-83.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0354] Table A-84 provides 14 compounds A-84.001 to A-84.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0355] Table A-85 provides 14 compounds A-85.001 to A-85.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0356] Table A-86 provides 14 compounds A-86.001 to A-86.014 of formula I-1-Qb, where R1 CF 3 and R 2 is CH 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0357] Table A-87 provides 14 compounds A-87.001 to A-87.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0358] Table A-88 provides 14 compounds A-88.001 to A-88.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0359] Table A-89 provides 14 compounds A-89.001 to A-89.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0360] Table A-90 provides 14 compounds A-90.001 to A-90.014 of formula I-1-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH and X is SO2 and R 6 is as defined in Table B.
[0361] Table A-91 provides 14 compounds A-91.001 to A-91.014 of formula I-1-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0362] Table A-92 provides 14 compounds A-92.001 to A-92.014 of formula I-1-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0363] Table A-93 provides 14 compounds A-93.001 to A-93.014 of formula I-1-Qb, where R 1 CF 3 and R 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0364] Table A-94 provides 14 compounds A-94.001 to A-94.014 of formula I-1-Qb, where R 1 CF 3 and R 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0365] Table A-95 provides 14 compounds A-95.001 to A-95.014 of formula I-1-Qb, where R 1 CF3 and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0366] Table A-96 provides 14 compounds A-96.001 to A-96.014 of formula I-1-Qb, where R 1 CF 3 and R 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0367] Tables C-1 to C-96 below further illustrate certain compounds of the present invention.
[0368] "cPr" stands for cyclopropyl. [ka]
[0369] Table C-1 provides seven compounds C-1.001 to C-1.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0370] [Table 2]
[0371] Table C-2 provides seven compounds C-2.001 to C-2.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0372] Table C-3 provides seven compounds C-3.001 to C-3.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0373] Table C-4 provides seven compounds C-4.001 to C-4.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0374] Table C-5 provides seven compounds C-5.001 to C-5.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0375] Table C-6 provides seven compounds C-6.001 to C-6.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0376] Table C-7 provides seven compounds C-7.001 to C-7.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0377] Table C-8 provides seven compounds C-8.001 to C-8.007 of formula I-1-Qa, where A is N, X is S, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0378] Table C-9 provides seven compounds C-9.001 to C-9.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0379] Table C-10 provides seven compounds C-10.001 to C-10.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0380] Table C-11 provides seven compounds C-11.001 to C-11.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0381] Table C-12 provides seven compounds C-12.001 to C-12.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0382] Table C-13 provides seven compounds C-13.001 to C-13.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0383] Table C-14 provides seven compounds C-14.001 to C-14.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0384] Table C-15 provides seven compounds C-15.001 to C-15.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0385] Table C-16 provides seven compounds C-16.001 to C-16.007 of formula I-1-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0386] Table C-17 provides seven compounds C-17.001 to C-17.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0387] Table C-18 provides seven compounds C-18.001 to C-18.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0388] Table C-19 provides seven compounds C-19.001 to C-19.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0389] Table C-20 provides seven compounds C-20.001 to C-20.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0390] Table C-21 provides seven compounds C-21.001 to C-21.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0391] Table C-22 provides seven compounds C-22.001 to C-22.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0392] Table C-23 provides seven compounds C-23.001 to C-23.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0393] Table C-24 provides seven compounds C-24.001 to C-24.007 of formula I-1-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0394] Table C-25 provides seven compounds C-25.001 to C-25.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0395] Table C-26 provides seven compounds C-26.001 to C-26.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0396] Table C-27 provides seven compounds C-27.001 to C-27.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0397] Table C-28 provides seven compounds C-28.001 to C-28.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0398] Table C-29 provides seven compounds C-29.001 to C-29.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0399] Table C-30 provides seven compounds C-30.001 to C-30.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0400] Table C-31 provides seven compounds C-31.001 to C-31.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0401] Table C-32 provides seven compounds C-32.001 to C-32.007 of formula I-1-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0402] Table C-33 provides seven compounds C-33.001 to C-33.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0403] Table C-34 provides seven compounds C-34.001 to C-34.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0404] Table C-35 provides seven compounds C-35.001 to C-35.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0405] Table C-36 provides seven compounds C-36.001 to C-36.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0406] Table C-37 provides seven compounds C-37.001 to C-37.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2is Me and R 5 is as defined in Table D.
[0407] Table C-38 provides seven compounds C-38.001 to C-38.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0408] Table C-39 provides seven compounds C-39.001 to C-39.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0409] Table C-40 provides seven compounds C-40.001 to C-40.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0410] Table C-41 provides seven compounds C-41.001 to C-41.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0411] Table C-42 provides seven compounds C-42.001 to C-42.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0412] Table C-43 provides seven compounds C-43.001 to C-43.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0413] Table C-44 provides seven compounds C-44.001 to C-44.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0414] Table C-45 provides seven compounds C-45.001 to C-45.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0415] Table C-46 provides seven compounds C-46.001 to C-46.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5is as defined in Table D.
[0416] Table C-47 provides seven compounds C-47.001 to C-47.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0417] Table C-48 provides seven compounds C-48.001 to C-48.007 of formula I-1-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0418] Table C-49 provides seven compounds C-49.001 to C-49.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0419] Table C-50 provides seven compounds C-50.001 to C-50.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0420] Table C-51 provides seven compounds C-51.001 to C-51.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R2 COCH 3 and R 5 is as defined in Table D.
[0421] Table C-52 provides seven compounds C-52.001 to C-52.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0422] Table C-53 provides seven compounds C-53.001 to C-53.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0423] Table C-54 provides seven compounds C-54.001 to C-54.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0424] Table C-55 provides seven compounds C-55.001 to C-55.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0425] Table C-56 provides seven compounds C-56.001 to C-56.007 of formula I-1-Qa, where A is CH, X is S, and R 1 CF 3and R 2 CF 3 and R 5 is as defined in Table D.
[0426] Table C-57 provides seven compounds C-57.001 to C-57.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0427] Table C-58 provides seven compounds C-58.001 to C-58.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0428] Table C-59 provides seven compounds C-59.001 to C-59.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0429] Table C-60 provides seven compounds C-60.001 to C-60.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0430] Table C-61 provides seven compounds C-61.001 to C-61.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R2 is Me and R 5 is as defined in Table D.
[0431] Table C-62 provides seven compounds C-62.001 to C-62.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0432] Table C-63 provides seven compounds C-63.001 to C-63.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0433] Table C-64 provides seven compounds C-64.001 to C-64.007 of formula I-1-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0434] Table C-65 provides seven compounds C-65.001 to C-65.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0435] Table C-66 provides seven compounds C-66.001 to C-66.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3and R 2 is CN and R 5 is as defined in Table D.
[0436] Table C-67 provides seven compounds C-67.001 to C-67.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0437] Table C-68 provides seven compounds C-68.001 to C-68.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0438] Table C-69 provides seven compounds C-69.001 to C-69.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0439] Table C-70 provides seven compounds C-70.001 to C-70.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0440] Table C-71 provides seven compounds C-71.001 to C-71.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0441] Table C-72 provides seven compounds C-72.001 to C-72.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0442] Table C-73 provides seven compounds C-73.001 to C-73.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0443] Table C-74 provides seven compounds C-74.001 to C-74.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0444] Table C-75 provides seven compounds C-75.001 to C-75.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0445] Table C-76 provides seven compounds C-76.001 to C-76.007 of formula I-1-Qa, where A is CH, X is SO, and R 1is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0446] Table C-77 provides seven compounds C-77.001 to C-77.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0447] Table C-78 provides seven compounds C-78.001 to C-78.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0448] Table C-79 provides seven compounds C-79.001 to C-79.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0449] Table C-80 provides seven compounds C-80.001 to C-80.007 of formula I-1-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0450] Table C-81 provides seven compounds C-81.001 to C-81.007 of formula I-1-Qa, where A is CH and X is SO2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0451] Table C-82 provides seven compounds C-82.001 to C-82.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0452] Table C-83 provides seven compounds C-83.001 to C-83.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0453] Table C-84 provides seven compounds C-84.001 to C-84.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0454] Table C-85 provides seven compounds C-85.001 to C-85.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0455] Table C-86 provides seven compounds C-86.001 to C-86.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0456] Table C-87 provides seven compounds C-87.001 to C-87.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0457] Table C-88 provides seven compounds C-88.001 to C-88.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0458] Table C-89 provides seven compounds C-89.001 to C-89.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0459] Table C-90 provides seven compounds C-90.001 to C-90.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2is CN and R 5 is as defined in Table D.
[0460] Table C-91 provides seven compounds C-91.001 to C-91.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0461] Table C-92 provides seven compounds C-92.001 to C-92.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0462] Table C-93 provides seven compounds C-93.001 to C-93.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0463] Table C-94 provides seven compounds C-94.001 to C-94.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0464] Table C-95 provides seven compounds C-95.001 to C-95.007 of formula I-1-Qa, where A is CH and X is SO 2and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0465] Table C-96 provides seven compounds C-96.001 to C-96.007 of formula I-1-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0466] Tables E-1 to E-96 below further exemplify certain compounds of the present invention.
[0467] "cPr" stands for cyclopropyl. [ka]
[0468] Table E-1 provides 14 compounds E-1.001 to E-1.014 of formula I-2-Qb, where R 1 is Me and R 2 is H, A is N, X is S, and R 6 is as defined in Table B.
[0469] Table E-2 provides 14 compounds E-2.001 to E-2.014 of formula I-2-Qb, where R 1 is Me and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0470] Table E-3 provides 14 compounds E-3.001 to E-3.014 of formula I-2-Qb, where R 1 is Me and R2 is H, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0471] Table E-4 provides 14 compounds E-4.001 to E-4.014 of formula I-2-Qb, where R 1 is Me and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0472] Table E-5 provides 14 compounds E-5.001 to E-5.014 of formula I-2-Qb, where R 1 is Me and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0473] Table E-6 provides 14 compounds E-6.001 to E-6.014 of formula I-2-Qb, where R 1 is Me and R 2 is H, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0474] Table E-7 provides 14 compounds E-7.001 to E-7.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0475] Table E-8 provides 14 compounds E-8.001 to E-8.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is N, X is SO, and R 6 is as defined in Table B.
[0476] Table E-9 provides 14 compounds E-9.001 to E-9.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0477] Table E-10 provides 14 compounds E-10.001 to E-10.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0478] Table E-11 provides 14 compounds E-11.001 to E-11.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is CH, X is SO, and R 6 is as defined in Table B.
[0479] Table E-12 provides 14 compounds E-12.001 to E-12.014 of formula I-2-Qb, where R 1 is Me and R 2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0480] Table E-13 provides 14 compounds E-13.001 to E-13.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is S, and R 6 is as defined in Table B.
[0481] Table E-14 provides 14 compounds E-14.001 to E-14.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0482] Table E-15 provides 14 compounds E-15.001 to E-15.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0483] Table E-16 provides 14 compounds E-16.001 to E-16.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0484] Table E-17 provides 14 compounds E-17.001 to E-17.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0485] Table E-18 provides 14 compounds E-18.001 to E-18.014 of formula I-2-Qb, where R 1 is Me and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0486] Table E-19 provides 14 compounds E-19.001 to E-19.014 of formula I-2-Qb, where R 1 is Me and R 2 is cPr, A is N, X is S, and R 6 is as defined in Table B.
[0487] Table E-20 provides 14 compounds E-20.001 to E-20.014 of formula I-2-Qb, where R 1 is Me and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0488] Table E-21 provides 14 compounds E-21.001 to E-21.014 of formula I-2-Qb, where R 1 is Me and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0489] Table E-22 provides 14 compounds E-22.001 to E-22.014 of formula I-2-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is S, and R 6 is as defined in Table B.
[0490] Table E-23 provides 14 compounds E-23.001 to E-23.014 of formula I-2-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0491] Table E-24 provides 14 compounds E-24.001 to E-24.014 of formula I-2-Qb, where R 1is Me and R 2 is cPr, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0492] Table E-25 provides 14 compounds E-25.001 to E-25.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0493] Table E-26 provides 14 compounds E-26.001 to E-26.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0494] Table E-27 provides 14 compounds E-27.001 to E-27.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0495] Table E-28 provides 14 compounds E-28.001 to E-28.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0496] Table E-29 provides 14 compounds E-29.001 to E-29.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is CH, X is SO, and R 6is as defined in Table B.
[0497] Table E-30 provides 14 compounds E-30.001 to E-30.014 of formula I-2-Qb, where R 1 is Me and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0498] Table E-31 provides 14 compounds E-31.001 to E-31.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is N, X is S, and R 6 is as defined in Table B.
[0499] Table E-32 provides 14 compounds E-32.001 to E-32.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0500] Table E-33 provides 14 compounds E-33.001 to E-33.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0501] Table E-34 provides 14 compounds E-34.001 to E-34.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is CH, X is S, and R 6 is as defined in Table B.
[0502] Table E-35 provides 14 compounds E-35.001 to E-35.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0503] Table E-36 provides 14 compounds E-36.001 to E-36.014 of formula I-2-Qb, where R 1 is Me and R 2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0504] Table E-37 provides 14 compounds E-37.001 to E-37.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0505] Table E-38 provides 14 compounds E-38.001 to E-38.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0506] Table E-39 provides 14 compounds E-39.001 to E-39.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0507] Table E-40 provides 14 compounds E-40.001 to E-40.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0508] Table E-41 provides 14 compounds E-41.001 to E-41.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0509] Table E-42 provides 14 compounds E-42.001 to E-42.014 of formula I-2-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0510] Table E-43 provides 14 compounds E-43.001 to E-43.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0511] Table E-44 provides 14 compounds E-44.001 to E-44.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is N, X is SO, and R 6is as defined in Table B.
[0512] Table E-45 provides 14 compounds E-45.001 to E-45.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0513] Table E-46 provides 14 compounds E-46.001 to E-46.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0514] Table E-47 provides 14 compounds E-47.001 to E-47.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0515] Table E-48 provides 14 compounds E-48.001 to E-48.014 of formula I-2-Qb, where R 1 is Me and R 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0516] Table E-49 provides 14 compounds E-49.001 to E-49.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is N, X is S, and R 6is as defined in Table B.
[0517] Table E-50 provides 14 compounds E-50.001 to E-50.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0518] Table E-51 provides 14 compounds E-51.001 to E-51.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0519] Table E-52 provides 14 compounds E-52.001 to E-52.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0520] Table E-53 provides 14 compounds E-53.001 to E-53.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0521] Table E-54 provides 14 compounds E-54.001 to E-54.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is H, A is CH, and X is SO 2 and R 6is as defined in Table B.
[0522] Table E-55 provides 14 compounds E-55.001 to E-55.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0523] Table E-56 provides 14 compounds E-56.001 to E-56.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is SO, and R 6 is as defined in Table B.
[0524] Table E-57 provides 14 compounds E-57.001 to E-57.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0525] Table E-58 provides 14 compounds E-58.001 to E-58.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0526] Table E-59 provides 14 compounds E-59.001 to E-59.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is SO, and R 6is as defined in Table B.
[0527] Table E-60 provides 14 compounds E-60.001 to E-60.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0528] Table E-61 provides 14 compounds E-61.001 to E-61.014 of formula I-2-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is S, and R 6 is as defined in Table B.
[0529] Table E-62 provides 14 compounds E-62.001 to E-62.014 of formula I-2-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0530] Table E-63 provides 14 compounds E-63.001 to E-63.014 of formula I-2-Qb, where R 1 CF 3 and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0531] Table E-64 provides 14 compounds E-64.001 to E-64.014 of formula I-2-Qb, where R 1 CF 3 and R 2COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0532] Table E-65 provides 14 compounds E-65.001 to E-65.014 of formula I-2-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0533] Table E-66 provides 14 compounds E-66.001 to E-66.014 of formula I-2-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0534] Table E-67 provides 14 compounds E-67.001 to E-67.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is S, and R 6 is as defined in Table B.
[0535] Table E-68 provides 14 compounds E-68.001 to E-68.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0536] Table E-69 provides 14 compounds E-69.001 to E-69.014 of formula I-2-Qb, where R 1 CF3 and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0537] Table E-70 provides 14 compounds E-70.001 to E-70.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, X is S, and R 6 is as defined in Table B.
[0538] Table E-71 provides 14 compounds E-71.001 to E-71.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0539] Table E-72 provides 14 compounds E-72.001 to E-72.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0540] Table E-73 provides 14 compounds E-73.001 to E-73.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0541] Table E-74 provides 14 compounds E-74.001 to E-74.014 of formula I-2-Qb, where R 1 CF3 and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0542] Table E-75 provides 14 compounds E-75.001 to E-75.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0543] Table E-76 provides 14 compounds E-76.001 to E-76.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0544] Table E-77 provides 14 compounds E-77.001 to E-77.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Me, A is CH, X is SO, and R 6 is as defined in Table B.
[0545] Table E-78 provides 14 compounds E-78.001 to E-78.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0546] Table E-79 provides 14 compounds E-79.001 to E-79.014 of formula I-2-Qb, where R 1 CF3 and R 2 is Et, A is N, X is S, and R 6 is as defined in Table B.
[0547] Table E-80 provides 14 compounds E-80.001 to E-80.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0548] Table E-81 provides 14 compounds E-81.001 to E-81.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0549] Table E-82 provides 14 compounds E-82.001 to E-82.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is S, and R 6 is as defined in Table B.
[0550] Table E-83 provides 14 compounds E-83.001 to E-83.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0551] Table E-84 provides 14 compounds E-84.001 to E-84.014 of formula I-2-Qb, where R 1 CF 3 and R2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0552] Table E-85 provides 14 compounds E-85.001 to E-85.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0553] Table E-86 provides 14 compounds E-86.001 to E-86.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0554] Table E-87 provides 14 compounds E-87.001 to E-87.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0555] Table E-88 provides 14 compounds E-88.001 to E-88.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0556] Table E-89 provides 14 compounds E-89.001 to E-89.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0557] Table E-90 provides 14 compounds E-90.001 to E-90.014 of formula I-2-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0558] Table E-91 provides 14 compounds E-91.001 to E-91.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0559] Table E-92 provides 14 compounds E-92.001 to E-92.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0560] Table E-93 provides 14 compounds E-93.001 to E-93.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0561] Table E-94 provides 14 compounds E-94.001 to E-94.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0562] Table E-95 provides 14 compounds E-95.001 to E-95.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0563] Table E-96 provides 14 compounds E-96.001 to E-96.014 of formula I-2-Qb, where R 1 CF 3 and R 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0564] Tables F-1 to F-96 below further illustrate certain compounds of the present invention.
[0565] "cPr" stands for cyclopropyl. [ka]
[0566] Table F-1 provides seven compounds F-1.001 to F-1.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0567] Table F-2 provides seven compounds F-2.001 to F-2.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0568] Table F-3 provides seven compounds F-3.001 to F-3.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0569] Table F-4 provides seven compounds F-4.001 to F-4.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0570] Table F-5 provides seven compounds F-5.001 to F-5.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0571] Table F-6 provides seven compounds F-6.001 to F-6.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0572] Table F-7 provides seven compounds F-7.001 to F-7.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0573] Table F-8 provides seven compounds F-8.001 to F-8.007 of formula I-2-Qa, where A is N, X is S, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0574] Table F-9 provides seven compounds F-9.001 to F-9.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0575] Table F-10 provides seven compounds F-10.001 to F-10.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0576] Table F-11 provides seven compounds F-11.001 to F-11.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0577] Table F-12 provides seven compounds F-12.001 to F-12.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0578] Table F-13 provides seven compounds F-13.001 to F-13.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0579] Table F-14 provides seven compounds F-14.001 to F-14.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0580] Table F-15 provides seven compounds F-15.001 to F-15.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0581] Table F-16 provides seven compounds F-16.001 to F-16.007 of formula I-2-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0582] Table F-17 provides seven compounds F-17.001 to F-17.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0583] Table F-18 provides seven compounds F-18.001 to F-18.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0584] Table F-19 provides seven compounds F-19.001 to F-19.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0585] Table F-20 provides seven compounds F-20.001 to F-20.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0586] Table F-21 provides seven compounds F-21.001 to F-21.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0587] Table F-22 provides seven compounds F-22.001 to F-22.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0588] Table F-23 provides seven compounds F-23.001 to F-23.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0589] Table F-24 provides seven compounds F-24.001 to F-24.007 of formula I-2-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0590] Table F-25 provides seven compounds F-25.001 to F-25.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0591] Table F-26 provides seven compounds F-26.001 to F-26.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0592] Table F-27 provides seven compounds F-27.001 to F-27.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0593] Table F-28 provides seven compounds F-28.001 to F-28.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0594] Table F-29 provides seven compounds F-29.001 to F-29.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0595] Table F-30 provides seven compounds F-30.001 to F-30.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0596] Table F-31 provides seven compounds F-31.001 to F-31.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0597] Table F-32 provides seven compounds F-32.001 to F-32.007 of formula I-2-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0598] Table F-33 provides seven compounds F-33.001 to F-33.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0599] Table F-34 provides seven compounds F-34.001 to F-34.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0600] Table F-35 provides seven compounds F-35.001 to F-35.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 COCH 3 and R 5is as defined in Table D.
[0601] Table F-36 provides seven compounds F-36.001 to F-36.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0602] Table F-37 provides seven compounds F-37.001 to F-37.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0603] Table F-38 provides seven compounds F-38.001 to F-38.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0604] Table F-39 provides seven compounds F-39.001 to F-39.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0605] Table F-40 provides seven compounds F-40.001 to F-40.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0606] Table F-41 provides seven compounds F-41.001 to F-41.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0607] Table F-42 provides seven compounds F-42.001 to F-42.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0608] Table F-43 provides seven compounds F-43.001 to F-43.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0609] Table F-44 provides seven compounds F-44.001 to F-44.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0610] Table F-45 provides seven compounds F-45.001 to F-45.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0611] Table F-46 provides seven compounds F-46.001 to F-46.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0612] Table F-47 provides seven compounds F-47.001 to F-47.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0613] Table F-48 provides seven compounds F-48.001 to F-48.007 of formula I-2-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0614] Table F-49 provides seven compounds F-49.001 to F-49.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is H and R 5is as defined in Table D.
[0615] Table F-50 provides seven compounds F-50.001 to F-50.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0616] Table F-51 provides seven compounds F-51.001 to F-51.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0617] Table F-52 provides seven compounds F-52.001 to F-52.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0618] Table F-53 provides seven compounds F-53.001 to F-53.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0619] Table F-54 provides seven compounds F-54.001 to F-54.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0620] Table F-55 provides seven compounds F-55.001 to F-55.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0621] Table F-56 provides seven compounds F-56.001 to F-56.007 of formula I-2-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0622] Table F-57 provides seven compounds F-57.001 to F-57.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0623] Table F-58 provides seven compounds F-58.001 to F-58.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0624] Table F-59 provides seven compounds F-59.001 to F-59.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5is as defined in Table D.
[0625] Table F-60 provides seven compounds F-60.001 to F-60.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0626] Table F-61 provides seven compounds F-61.001 to F-61.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0627] Table F-62 provides seven compounds F-62.001 to F-62.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0628] Table F-63 provides seven compounds F-63.001 to F-63.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0629] Table F-64 provides seven compounds F-64.001 to F-64.007 of formula I-2-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 CF 3 and R5 is as defined in Table D.
[0630] Table F-65 provides seven compounds F-65.001 to F-65.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0631] Table F-66 provides seven compounds F-66.001 to F-66.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0632] Table F-67 provides seven compounds F-67.001 to F-67.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0633] Table F-68 provides seven compounds F-68.001 to F-68.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0634] Table F-69 provides seven compounds F-69.001 to F-69.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Me and R 5is as defined in Table D.
[0635] Table F-70 provides seven compounds F-70.001 to F-70.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0636] Table F-71 provides seven compounds F-71.001 to F-71.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0637] Table F-72 provides seven compounds F-72.001 to F-72.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0638] Table F-73 provides seven compounds F-73.001 to F-73.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0639] Table F-74 provides seven compounds F-74.001 to F-74.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CN and R5 is as defined in Table D.
[0640] Table F-75 provides seven compounds F-75.001 to F-75.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0641] Table F-76 provides seven compounds F-76.001 to F-76.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0642] Table F-77 provides seven compounds F-77.001 to F-77.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0643] Table F-78 provides seven compounds F-78.001 to F-78.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0644] Table F-79 provides seven compounds F-79.001 to F-79.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF3 and R 5 is as defined in Table D.
[0645] Table F-80 provides seven compounds F-80.001 to F-80.007 of formula I-2-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0646] Table F-81 provides seven compounds F-81.001 to F-81.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0647] Table F-82 provides seven compounds F-82.001 to F-82.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0648] Table F-83 provides seven compounds F-83.001 to F-83.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0649] Table F-84 provides seven compounds F-84.001 to F-84.007 of formula I-2-Qa, where A is CH and X is SO 2and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0650] Table F-85 provides seven compounds F-85.001 to F-85.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0651] Table F-86 provides seven compounds F-86.001 to F-86.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0652] Table F-87 provides seven compounds F-87.001 to F-87.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0653] Table F-88 provides seven compounds F-88.001 to F-88.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0654] Table F-89 provides seven compounds F-89.001 to F-89.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0655] Table F-90 provides seven compounds F-90.001 to F-90.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0656] Table F-91 provides seven compounds F-91.001 to F-91.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0657] Table F-92 provides seven compounds F-92.001 to F-92.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0658] Table F-93 provides seven compounds F-93.001 to F-93.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5is as defined in Table D.
[0659] Table F-94 provides seven compounds F-94.001 to F-94.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0660] Table F-95 provides seven compounds F-95.001 to F-95.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0661] Table F-96 provides seven compounds F-96.001 to F-96.007 of formula I-2-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0662] Tables G-1 through G-96 below further exemplify certain compounds of the present invention.
[0663] "cPr" stands for cyclopropyl. [ka]
[0664] Table G-1 provides 14 compounds G-1.001 to G-1.014 of formula I-3-Qb, where R 1 is Me and R 2is H, A is N, X is S, and R 6 is as defined in Table B.
[0665] Table G-2 provides 14 compounds G-2.001 to G-2.014 of formula I-3-Qb, where R 1 is Me and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0666] Table G-3 provides 14 compounds G-3.001 to G-3.014 of formula I-3-Qb, where R 1 is Me and R 2 is H, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0667] Table G-4 provides 14 compounds G-4.001 to G-4.014 of formula I-3-Qb, where R 1 is Me and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0668] Table G-5 provides 14 compounds G-5.001 to G-5.014 of formula I-3-Qb, where R 1 is Me and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0669] Table G-6 provides 14 compounds G-6.001 to G-6.014 of formula I-3-Qb, where R 1 is Me and R 2 is H, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0670] Table G-7 provides 14 compounds G-7.001 to G-7.014 of formula I-3-Qb, where R 1 is Me and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0671] Table G-8 provides 14 compounds G-8.001 to G-8.014 of formula I-3-Qb, where R 1 is Me and R 2 is CN, A is N, X is SO, and R 6 is as defined in Table B.
[0672] Table G-9 provides 14 compounds G-9.001 to G-9.014 of formula I-3-Qb, where R 1 is Me and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0673] Table G-10 provides 14 compounds G-10.001 to G-10.014 of formula I-3-Qb, where R 1 is Me and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0674] Table G-11 provides 14 compounds G-11.001 to G-11.014 of formula I-3-Qb, where R 1 is Me and R 2 is CN, A is CH, X is SO, and R 6 is as defined in Table B.
[0675] Table G-12 provides 14 compounds G-12.001 to G-12.014 of formula I-3-Qb, where R 1 is Me and R2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0676] Table G-13 provides 14 compounds G-13.001 to G-13.014 of formula I-3-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is S, and R 6 is as defined in Table B.
[0677] Table G-14 provides 14 compounds G-14.001 to G-14.014 of formula I-3-Qb, where R 1 is Me and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0678] Table G-15 provides 14 compounds G-15.001 to G-15.014 of formula I-3-Qb, where R 1 is Me and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0679] Table G-16 provides 14 compounds G-16.001 to G-16.014 of formula I-3-Qb, where R 1 is Me and R 2 COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0680] Table G-17 provides 14 compounds G-17.001 to G-17.014 of formula I-3-Qb, where R 1 is Me and R 2COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0681] Table G-18 provides 14 compounds G-18.001 to G-18.014 of formula I-3-Qb, where R 1 is Me and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0682] Table G-19 provides 14 compounds G-19.001 to G-19.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is N, X is S, and R 6 is as defined in Table B.
[0683] Table G-20 provides 14 compounds G-20.001 to G-20.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0684] Table G-21 provides 14 compounds G-21.001 to G-21.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0685] Table G-22 provides 14 compounds G-22.001 to G-22.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is S, and R6 is as defined in Table B.
[0686] Table G-23 provides 14 compounds G-23.001 to G-23.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0687] Table G-24 provides 14 compounds G-24.001 to G-24.014 of formula I-3-Qb, where R 1 is Me and R 2 is cPr, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0688] Table G-25 provides 14 compounds G-25.001 to G-25.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0689] Table G-26 provides 14 compounds G-26.001 to G-26.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0690] Table G-27 provides 14 compounds G-27.001 to G-27.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0691] Table G-28 provides 14 compounds G-28.001 to G-28.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0692] Table G-29 provides 14 compounds G-29.001 to G-29.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is CH, X is SO, and R 6 is as defined in Table B.
[0693] Table G-30 provides 14 compounds G-30.001 to G-30.014 of formula I-3-Qb, where R 1 is Me and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0694] Table G-31 provides 14 compounds G-31.001 to G-31.014 of formula I-3-Qb, where R 1 is Me and R 2 is Et, A is N, X is S, and R 6 is as defined in Table B.
[0695] Table G-32 provides 14 compounds G-32.001 to G-32.014 of formula I-3-Qb, where R 1 is Me and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0696] Table G-33 provides 14 compounds G-33.001 to G-33.014 of formula I-3-Qb, where R 1 is Me and R 2is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0697] Table G-34 provides 14 compounds G-34.001 to G-34.014 of formula I-3-Qb, where R 1 is Me and R 2 is Et, A is CH, X is S, and R 6 is as defined in Table B.
[0698] Table G-35 provides 14 compounds G-35.001 to G-35.014 of formula I-3-Qb, where R 1 is Me and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0699] Table G-36 provides 14 compounds G-36.001 to G-36.014 of formula I-3-Qb, where R 1 is Me and R 2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0700] Table G-37 provides 14 compounds G-37.001 to G-37.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0701] Table G-38 provides 14 compounds G-38.001 to G-38.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3A is N, X is SO, and R 6 is as defined in Table B.
[0702] Table G-39 provides 14 compounds G-39.001 to G-39.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0703] Table G-40 provides 14 compounds G-40.001 to G-40.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0704] Table G-41 provides 14 compounds G-41.001 to G-41.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0705] Table G-42 provides 14 compounds G-42.001 to G-42.014 of formula I-3-Qb, where R 1 is Me and R 2 is CH 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0706] Table G-43 provides 14 compounds G-43.001 to G-43.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0707] Table G-44 provides 14 compounds G-44.001 to G-44.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0708] Table G-45 provides 14 compounds G-45.001 to G-45.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0709] Table G-46 provides 14 compounds G-46.001 to G-46.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0710] Table G-47 provides 14 compounds G-47.001 to G-47.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0711] Table G-48 provides 14 compounds G-48.001 to G-48.014 of formula I-3-Qb, where R 1 is Me and R 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0712] Table G-49 provides 14 compounds G-49.001 to G-49.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is N, X is S, and R 6 is as defined in Table B.
[0713] Table G-50 provides 14 compounds G-50.001 to G-50.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is N, X is SO, and R 6 is as defined in Table B.
[0714] Table G-51 provides 14 compounds G-51.001 to G-51.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0715] Table G-52 provides 14 compounds G-52.001 to G-52.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is S, and R 6 is as defined in Table B.
[0716] Table G-53 provides 14 compounds G-53.001 to G-53.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is CH, X is SO, and R 6 is as defined in Table B.
[0717] Table G-54 provides 14 compounds G-54.001 to G-54.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is H, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0718] Table G-55 provides 14 compounds G-55.001 to G-55.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is S, and R 6 is as defined in Table B.
[0719] Table G-56 provides 14 compounds G-56.001 to G-56.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is N, X is SO, and R 6 is as defined in Table B.
[0720] Table G-57 provides 14 compounds G-57.001 to G-57.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0721] Table G-58 provides 14 compounds G-58.001 to G-58.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is S, and R 6 is as defined in Table B.
[0722] Table G-59 provides 14 compounds G-59.001 to G-59.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is CH, X is SO, and R 6 is as defined in Table B.
[0723] Table G-60 provides 14 compounds G-60.001 to G-60.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CN, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0724] Table G-61 provides 14 compounds G-61.001 to G-61.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is S, and R 6 is as defined in Table B.
[0725] Table G-62 provides 14 compounds G-62.001 to G-62.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is N, X is SO, and R 6 is as defined in Table B.
[0726] Table G-63 provides 14 compounds G-63.001 to G-63.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0727] Table G-64 provides 14 compounds G-64.001 to G-64.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH, X is S, and R 6 is as defined in Table B.
[0728] Table G-65 provides 14 compounds G-65.001 to G-65.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0729] Table G-66 provides 14 compounds G-66.001 to G-66.014 of formula I-3-Qb, where R 1 CF 3 and R 2 COCH 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0730] Table G-67 provides 14 compounds G-67.001 to G-67.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is S, and R6 is as defined in Table B.
[0731] Table G-68 provides 14 compounds G-68.001 to G-68.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is N, X is SO, and R 6 is as defined in Table B.
[0732] Table G-69 provides 14 compounds G-69.001 to G-69.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0733] Table G-70 provides 14 compounds G-70.001 to G-70.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, X is S, and R 6 is as defined in Table B.
[0734] Table G-71 provides 14 compounds G-71.001 to G-71.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, X is SO, and R 6 is as defined in Table B.
[0735] Table G-72 provides 14 compounds G-72.001 to G-72.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is cPr, A is CH, and X is SO 2 and R6 is as defined in Table B.
[0736] Table G-73 provides 14 compounds G-73.001 to G-73.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is N, X is S, and R 6 is as defined in Table B.
[0737] Table G-74 provides 14 compounds G-74.001 to G-74.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is N, X is SO, and R 6 is as defined in Table B.
[0738] Table G-75 provides 14 compounds G-75.001 to G-75.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0739] Table G-76 provides 14 compounds G-76.001 to G-76.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is CH, X is S, and R 6 is as defined in Table B.
[0740] Table G-77 provides 14 compounds G-77.001 to G-77.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is CH, X is SO, and R 6is as defined in Table B.
[0741] Table G-78 provides 14 compounds G-78.001 to G-78.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Me, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0742] Table G-79 provides 14 compounds G-79.001 to G-79.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is N, X is S, and R 6 is as defined in Table B.
[0743] Table G-80 provides 14 compounds G-80.001 to G-80.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is N, X is SO, and R 6 is as defined in Table B.
[0744] Table G-81 provides 14 compounds G-81.001 to G-81.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is N, and X is SO 2 and R 6 is as defined in Table B.
[0745] Table G-82 provides 14 compounds G-82.001 to G-82.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is S, and R 6is as defined in Table B.
[0746] Table G-83 provides 14 compounds G-83.001 to G-83.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is CH, X is SO, and R 6 is as defined in Table B.
[0747] Table G-84 provides 14 compounds G-84.001 to G-84.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is Et, A is CH, and X is SO 2 and R 6 is as defined in Table B.
[0748] Table G-85 provides 14 compounds G-85.001 to G-85.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0749] Table G-86 provides 14 compounds G-86.001 to G-86.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0750] Table G-87 provides 14 compounds G-87.001 to G-87.014 of formula I-3-Qb, where R 1 CF 3 and R 2is CH 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0751] Table G-88 provides 14 compounds G-88.001 to G-88.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0752] Table G-89 provides 14 compounds G-89.001 to G-89.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0753] Table G-90 provides 14 compounds G-90.001 to G-90.014 of formula I-3-Qb, where R 1 CF 3 and R 2 is CH 2 CF 3 A is CH and X is SO 2 and R 6 is as defined in Table B.
[0754] Table G-91 provides 14 compounds G-91.001 to G-91.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is S, and R 6 is as defined in Table B.
[0755] Table G-92 provides 14 compounds G-92.001 to G-92.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is N, X is SO, and R 6 is as defined in Table B.
[0756] Table G-93 provides 14 compounds G-93.001 to G-93.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is N and X is SO 2 and R 6 is as defined in Table B.
[0757] Table G-94 provides 14 compounds G-94.001 to G-94.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is CH, X is S, and R 6 is as defined in Table B.
[0758] Table G-95 provides 14 compounds G-95.001 to G-95.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is CH, X is SO, and R 6 is as defined in Table B.
[0759] Table G-96 provides 14 compounds G-96.001 to G-96.014 of formula I-3-Qb, where R 1 CF 3 and R 2 CF 3 A is CH and X is SO2 and R 6 is as defined in Table B.
[0760] Tables H-1 to H-96 below further exemplify certain compounds of the invention.
[0761] "cPr" stands for cyclopropyl. [ka]
[0762] Table H-1 provides seven compounds H-1.001 to H-1.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0763] Table H-2 provides seven compounds H-2.001 to H-2.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0764] Table H-3 provides seven compounds H-3.001 to H-3.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0765] Table H-4 provides seven compounds H-4.001 to H-4.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is cPr and R 5is as defined in Table D.
[0766] Table H-5 provides seven compounds H-5.001 to H-5.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0767] Table H-6 provides seven compounds H-6.001 to H-6.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0768] Table H-7 provides seven compounds H-7.001 to H-7.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0769] Table H-8 provides seven compounds H-8.001 to H-8.007 of formula I-3-Qa, where A is N, X is S, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0770] Table H-9 provides seven compounds H-9.001 to H-9.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is H and R 5is as defined in Table D.
[0771] Table H-10 provides seven compounds H-10.001 to H-10.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0772] Table H-11 provides seven compounds H-11.001 to H-11.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0773] Table H-12 provides seven compounds H-12.001 to H-12.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0774] Table H-13 provides seven compounds H-13.001 to H-13.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0775] Table H-14 provides seven compounds H-14.001 to H-14.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0776] Table H-15 provides seven compounds H-15.001 to H-15.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0777] Table H-16 provides seven compounds H-16.001 to H-16.007 of formula I-3-Qa, where A is N, X is S, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0778] Table H-17 provides seven compounds H-17.001 to H-17.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0779] Table H-18 provides seven compounds H-18.001 to H-18.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0780] Table H-19 provides seven compounds H-19.001 to H-19.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5is as defined in Table D.
[0781] Table H-20 provides seven compounds H-20.001 to H-20.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0782] Table H-21 provides seven compounds H-21.001 to H-21.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0783] Table H-22 provides seven compounds H-22.001 to H-22.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0784] Table H-23 provides seven compounds H-23.001 to H-23.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0785] Table H-24 provides seven compounds H-24.001 to H-24.007 of formula I-3-Qa, where A is N, X is SO, and R 1 CF 3 and R 2 CF 3 and R5 is as defined in Table D.
[0786] Table H-25 provides seven compounds H-25.001 to H-25.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0787] Table H-26 provides seven compounds H-26.001 to H-26.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0788] Table H-27 provides seven compounds H-27.001 to H-27.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0789] Table H-28 provides seven compounds H-28.001 to H-28.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0790] Table H-29 provides seven compounds H-29.001 to H-29.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Me and R 5is as defined in Table D.
[0791] Table H-30 provides seven compounds H-30.001 to H-30.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0792] Table H-31 provides seven compounds H-31.001 to H-31.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0793] Table H-32 provides seven compounds H-32.001 to H-32.007 of formula I-3-Qa, where A is N, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0794] Table H-33 provides seven compounds H-33.001 to H-33.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0795] Table H-34 provides seven compounds H-34.001 to H-34.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R2 is CN and R 5 is as defined in Table D.
[0796] Table H-35 provides seven compounds H-35.001 to H-35.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0797] Table H-36 provides seven compounds H-36.001 to H-36.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0798] Table H-37 provides seven compounds H-37.001 to H-37.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0799] Table H-38 provides seven compounds H-38.001 to H-38.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0800] Table H-39 provides seven compounds H-39.001 to H-39.007 of formula I-3-Qa, where A is N and X is SO2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0801] Table H-40 provides seven compounds H-40.001 to H-40.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0802] Table H-41 provides seven compounds H-41.001 to H-41.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0803] Table H-42 provides seven compounds H-42.001 to H-42.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0804] Table H-43 provides seven compounds H-43.001 to H-43.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0805] Table H-44 provides seven compounds H-44.001 to H-44.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0806] Table H-45 provides seven compounds H-45.001 to H-45.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0807] Table H-46 provides seven compounds H-46.001 to H-46.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0808] Table H-47 provides seven compounds H-47.001 to H-47.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0809] Table H-48 provides seven compounds H-48.001 to H-48.007 of formula I-3-Qa, where A is N and X is SO 2 and R 1 is CH 3 and R 2CF 3 and R 5 is as defined in Table D.
[0810] Table H-49 provides seven compounds H-49.001 to H-49.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0811] Table H-50 provides seven compounds H-50.001 to H-50.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0812] Table H-51 provides seven compounds H-51.001 to H-51.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0813] Table H-52 provides seven compounds H-52.001 to H-52.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0814] Table H-53 provides seven compounds H-53.001 to H-53.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2is Me and R 5 is as defined in Table D.
[0815] Table H-54 provides seven compounds H-54.001 to H-54.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0816] Table H-55 provides seven compounds H-55.001 to H-55.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0817] Table H-56 provides seven compounds H-56.001 to H-56.007 of formula I-3-Qa, where A is CH, X is S, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0818] Table H-57 provides seven compounds H-57.001 to H-57.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0819] Table H-58 provides seven compounds H-58.001 to H-58.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R2 is CN and R 5 is as defined in Table D.
[0820] Table H-59 provides seven compounds H-59.001 to H-59.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0821] Table H-60 provides seven compounds H-60.001 to H-60.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0822] Table H-61 provides seven compounds H-61.001 to H-61.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0823] Table H-62 provides seven compounds H-62.001 to H-62.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0824] Table H-63 provides seven compounds H-63.001 to H-63.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 is CH2 CF 3 and R 5 is as defined in Table D.
[0825] Table H-64 provides seven compounds H-64.001 to H-64.007 of formula I-3-Qa, where A is CH, X is S, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0826] Table H-65 provides seven compounds H-65.001 to H-65.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0827] Table H-66 provides seven compounds H-66.001 to H-66.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0828] Table H-67 provides seven compounds H-67.001 to H-67.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0829] Table H-68 provides seven compounds H-68.001 to H-68.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3and R 2 is cPr and R 5 is as defined in Table D.
[0830] Table H-69 provides seven compounds H-69.001 to H-69.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0831] Table H-70 provides seven compounds H-70.001 to H-70.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0832] Table H-71 provides seven compounds H-71.001 to H-71.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0833] Table H-72 provides seven compounds H-72.001 to H-72.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0834] Table H-73 provides seven compounds H-73.001 to H-73.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH3 and R 2 is H and R 5 is as defined in Table D.
[0835] Table H-74 provides seven compounds H-74.001 to H-74.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0836] Table H-75 provides seven compounds H-75.001 to H-75.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0837] Table H-76 provides seven compounds H-76.001 to H-76.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is cPr and R 5 is as defined in Table D.
[0838] Table H-77 provides seven compounds H-77.001 to H-77.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0839] Table H-78 provides seven compounds H-78.001 to H-78.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R2 is Et and R 5 is as defined in Table D.
[0840] Table H-79 provides seven compounds H-79.001 to H-79.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0841] Table H-80 provides seven compounds H-80.001 to H-80.007 of formula I-3-Qa, where A is CH, X is SO, and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0842] Table H-81 provides seven compounds H-81.001 to H-81.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is H and R 5 is as defined in Table D.
[0843] Table H-82 provides seven compounds H-82.001 to H-82.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CN and R 5 is as defined in Table D.
[0844] Table H-83 provides seven compounds H-83.001 to H-83.007 of formula I-3-Qa, where A is CH and X is SO2 and R 1 CF 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0845] Table H-84 provides seven compounds H-84.001 to H-84.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is cPr and R 5 is as defined in Table D.
[0846] Table H-85 provides seven compounds H-85.001 to H-85.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Me and R 5 is as defined in Table D.
[0847] Table H-86 provides seven compounds H-86.001 to H-86.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is Et and R 5 is as defined in Table D.
[0848] Table H-87 provides seven compounds H-87.001 to H-87.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0849] Table H-88 provides seven compounds H-88.001 to H-88.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 CF 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0850] Table H-89 provides seven compounds H-89.001 to H-89.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is H and R 5 is as defined in Table D.
[0851] Table H-90 provides seven compounds H-90.001 to H-90.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is CN and R 5 is as defined in Table D.
[0852] Table H-91 provides seven compounds H-91.001 to H-91.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 COCH 3 and R 5 is as defined in Table D.
[0853] Table H-92 provides seven compounds H-92.001 to H-92.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2is cPr and R 5 is as defined in Table D.
[0854] Table H-93 provides seven compounds H-93.001 to H-93.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Me and R 5 is as defined in Table D.
[0855] Table H-94 provides seven compounds H-94.001 to H-94.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is Et and R 5 is as defined in Table D.
[0856] Table H-95 provides seven compounds H-95.001 to H-95.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 is CH 2 CF 3 and R 5 is as defined in Table D.
[0857] Table H-96 provides seven compounds H-96.001 to H-96.007 of formula I-3-Qa, where A is CH and X is SO 2 and R 1 is CH 3 and R 2 CF 3 and R 5 is as defined in Table D.
[0858] The compounds of formula I according to the invention are active ingredients of high preventive and / or therapeutic value in the field of pest control, even at low application rates, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants. The active ingredients according to the invention act against all or each of the developmental stages of animal pests, such as insects or representatives of the order Acarina, which are usually susceptible but also resistant. The insecticidal or acaricidal activity of the active ingredients according to the invention can itself be directly manifested (i.e. the control of pests which occurs immediately or only after a certain time has elapsed (for example during molting)) or indirectly manifested (for example a reduction in egg-laying and / or hatching rate, a good activity corresponding to a control rate (mortality) of at least 50-60%).
[0859] Examples of the above animal pests are: From the order Acarina, for example, Acalitus spp., Aculus spp., Acaricalus spp., Aceria spp., Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp., Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp., Eotetranychus spp. spp., Eriophyes spp., Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Olygonychus spp., Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp., Polyphagotarsonemus spp., Psoroptes spp., Rhipicephalus spp. spp.), Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp., Tarsonemus spp. and Tetranychus spp.; From the order of the Anoplura, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.; From the order Coleoptera, for example, Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotoma spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp. spp.), Cyclocephala spp., Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera castanea, Megascelis spp., Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp., Phlyctinus spp.), Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabaeidae, Sitophilus spp., Sitotroga spp., Somaticus spp., Sphenophorus spp., Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp.;. From the order Diptera, for example, Aedes spp., Anopheles spp., Antherigona soccata, Bactrocea oleae, Bibio hortulanus, Bradysia spp., Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp., Drosophila melanogaster, Fannia spp. spp.), Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp. spp.), Rhagoletis spp., Rivelia quadrifasciata, Scatella spp., Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.; From the order Hemiptera, for example, Acanthocoris scabrator, Acrosternum spp., Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp., Cimex spp., Clavigrella tomentosicollis, Creontiades spp., Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp. spp., Euschistus spp., Eurydema pulchrum, Eurygaster spp., Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp., Margarodes spp., Murgantia histrionic, Neomegalotomus spp., Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis insularis, Piesma spp., Piezodorus spp., Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp.), Thyanta spp., Triatoma spp., Vatiga illudens;. Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp. spp.), Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp., Brachycaudus spp., Brevicoryne brassicae, Cacopsylla spp., Cavariella aegopodii Scop., Ceroplaster spp.), Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp., Cofana spectra, Cryptomyzus spp., Cicadulina spp., Coccus hesperidum, Dalbulus maidis, Dialeurodes spp., Diaphorina citri, Diuraphis noxia, Dysaphis spp., Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp., Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Corn scale (Lecanium corni), Lepidosaphes spp., False radish aphid (Lopaphis erysimi, Lyogenys maidis, Macrosiphum spp., Mahanarva spp., Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp.), Neotoxoptera sp., Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Bayberry whitefly, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Corn planthopper, Peregrinus maidis, Perkinsiella spp., Hop wart aphid, Phorodon humuli, Phylloxera spp., Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp. spp.), Schizaphis spp., Sitobion spp.), Sogatella furcifera, Spisstilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza erytreae, Unaspis citri, Zygina flammigera, Zyginidia scutellaris;. From the order of Hymenoptera, for example, Acromyrmex, Arge spp., Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplocampa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp., Slenopsis invicta, Solenopsis spp. and Vespa spp.; From the order Isoptera, for example, Coptotermes spp., Corniternes cumulans, Incisitermes spp., Macrotermes spp., Mastotermes spp., Microtermes spp., Reticulitermes spp.; Solenopsis geminate. From the order Lepidoptera, for example, the genera Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp., Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp., Crocidolomia binotalis, Cryptophlebia leucotoleta leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp.), Eldana saccharina, Ephestia spp., Epinotia spp., Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Grapholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp. spp., Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp., Noctua spp., Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp.), pine sawfly moth (Panolis flammea), Papaipema nebris, red cotton bug (Pectinophora gossypiela), coffee leafminer (Perileucoptera coffeella), Pseudaletia unipuncta, potato tuber moth (Phthorimaea operculella), cabbage white butterfly (Pieris rapae), Pieris spp., diamondback moth (Plutella xylostella), Prays spp., Pseudoplusia spp., Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp.), Sparaganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta and Yponomeuta spp.;. From the order Mallophaga, for example, Damalinea spp. and Trichodectes spp.; From the order of Orthoptera, for example, the genera Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp. and Schistocerca spp.; From the order Psocoptera, for example Liposcelis spp.; From the order Siphonaptera, for example, Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis; From the order Thysanoptera, for example, Calliothrips phaseoli, Frankliniella spp., Heliothrips spp., Hercinothrips spp., Parthenothrips spp., Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp.; From the order Thysanura, for example, the silverfish (Lepisma saccharina).
[0860] The active ingredients according to the invention can be used to control, i.e. suppress or destroy, pests of the above-mentioned types which occur in particular on plants, in particular on useful plants and ornamental plants in agriculture, horticulture and forestry, or on organs such as the fruits, flowers, leaves, stems, tubers or roots of such plants, whereby even plant organs which are formed at a later time remain protected from these pests.
[0861] Suitable target crops are in particular cereals such as wheat, barley, rye, oats, rice, maize or sorghum; beets such as sugar beet or fodder beet; fruits, such as pome fruits, stone fruits or soft fruits, for example apple, pear, plum, peach, almond, cherry or berries, for example strawberry, raspberry or blackberry; legumes, such as beans, lentils, peas or soybeans; rapeseed, mustard, poppy, olive, sunflower, palm, castor, cocoa or ground yam. nut; cucurbits, such as pumpkin, cucumber or melon; fibre plants, such as cotton, flax, hemp or jute; citrus fruits, such as orange, lemon, grapefruit or tangerine; vegetables, such as spinach, lettuce, asparagus, cabbage, carrot, onion, tomato, potato or pepper; plants of the Lauraceae family, such as avocado, cinnamon or camphor; and also tobacco, nuts, coffee, eggplant, sugar cane, tea, pepper, grapes, hops, plantain and latex plants.
[0862] The compositions and / or methods of the present invention may be used on any ornamental and / or vegetable crop, including flowers, shrubs, broadleaf trees and evergreens.
[0863] For example, the present invention may be used in any of the following ornamental plant species: Ageratum spp., Alonsoa spp., Anemone spp., Anisodontea capsenisis, Anthemis spp., Antirrhinum spp., Aster spp., Begonia spp. (e.g. B. elatior, B. semperflorens, B. tubereux), Bougainvillea spp., Brachycome spp., Brassica spp., and the like. spp.) (ornamental plants), Calceolaria spp., Capsicum annuum, Catharanthus roseus, Canna spp., Centaurea spp., Chrysanthemum spp., Cineraria spp. (C. maritime), Coreopsis spp., Crassula coccinea, Cuphea ignea, Dahlia spp., Delphinium spp., Dicentra spectabilis, Dorotheantus spp.), Lisianthus (Eustoma grandiflorum), Forsythia spp., Fuchsia spp., Geranium gnaphalium, Gerbera spp., Gomphrena globosa, Heliotropium spp., Helianthus spp., Hibiscus spp., Hortensia spp.), Hydrangea spp., Hypoestes phyllostachya, Impatiens spp. (I. Walleriana), Iresines spp., Kalanchoe spp., Lantana camara, Lavatera trimestris, Leonotis leonurus, Lilium spp., Mesembryanthemum spp., Mimulus spp., Monarda spp., Nemesia spp., Tagetes spp. spp.), Dianthus spp. (carnations), Canna spp., Oxalis spp., Bellis spp., Pelargonium spp. (P. peltatum, P. Zonale), Viola spp. (pansies), Petunia spp., Phlox spp., Plecthranthus spp., Poinsettia spp., Parthenocissus spp. (P. quinquefolia, P. tricuspidata), Primula spp. spp.), Ranunculus spp., Rhododendron spp., Rosa spp. (roses), Rudbeckia spp., Saintpaulia spp., Salvia spp., Scaevola aemola, Schizanthus wisetonensis, Sedum spp., Solanum spp., Surfinia spp., Tagetes spp.), Nicotinia spp., Verbena spp., Zinnia spp. and other bedding plants.
[0864] For example, the present invention may be used with any of the following vegetable species: Allium spp. (garlic (A. sativum), onion (A. cepa), shallot (A. oschaninii), leek (A. Porrum), shallot (A. ascalonicum), green onion (A. fistulosum)), chervil (Anthriscus cerefolium), celery (Apium graveolus), asparagus (Asparagus officinalis), sugar beet (Beta vulgarus), Brassica spp. (B. Oleracea, Chinese cabbage (B. Pekinensis), turnip (B. rapa)), pepper (Capsicum annuum), chickpea (Cicer arietinum), endive (Cichorium endivia), chives (Cichorium spp.), thyme (Chrysanthemum vulgaris ... spp.) (chicory (C. intybus), endive (C. endivia)), watermelon (Citrillus lanatus), cucumber (Cucumis spp.) (saffron (C. sativus), melon (C. melo)), pumpkin (Cucurbita spp.) (Cucurbita pepo, C. maxima), Cyanara spp. (artichoke (C. scolymus), cardoon (C. cardunculus)), black carrot (Daucus carota), fennel (Foeniculum vulgare), Hypericum spp., lettuce (Lactuca sativa), tomato (Lycopersicon spp.) (tomato (L. esculentum), tomato (L. lycopersicum)), mint (Mentha spp.), basil (Ocimum basilicum), parsley (Petroselinum crispum), Phaseolus spp. (green bean (P. vulgaris), scarlet bean (P.coccineus), peas (Pisum sativum), radishes (Raphanus sativus), rhubarb (Rheum rhaponticum), rosemary (Rosemarinus spp.), butterbur (Salvia spp.), yellow rose (Scorzonera hispanica), eggplant (Solanum melongena), spinach (Spinacea oleracea), Valerianella spp. (Valerianella locusta, V. eriocarpa) and broad beans (Vicia faba).
[0865] Preferred ornamental plant species include African violet, Begonia, Dahlia, Gerbera, Hydrangea, Verbena, Rosa, Kalanchoe, Poinsettia, Aster, Centaurea, Coreopsis, Delphinium, Monarda, Phlox, and others. Examples of such herbs include Rudbeckia, Sedum, Petunia, Viola, Impatiens, Geranium, Chrysanthemum, Ranunculus, Fuchsia, Salvia, Hortensia, rosemary, sage, St. Johns wort, mint, pepper, tomato, and cucumber.
[0866] The active ingredients according to the invention are particularly suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, corn, rice and soybean crops. The active ingredients according to the invention are further particularly suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apple), Empoasca (preferably in vegetables, vineyards), Leptinotarsa (preferably in potato) and Chilo supressalis (preferably in rice).
[0867] The active ingredients according to the invention are particularly suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, corn, rice and soybean crops. The active ingredients according to the invention are further particularly suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apple), Empoasca (preferably in vegetables, vineyards), Leptinotarsa (preferably in potato) and Chilo supressalis (preferably in rice).
[0868] In a further aspect, the present invention relates to plant parasitic nematodes (endoparasitic, semi-endoparasitic and ectoparasitic nematodes), in particular root-knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species; cyst forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera clover cyst nematode, Heterodera trifolii and other Heterodera species; Root-knot nematodes, Anguina species; Spike and leaf nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species; Ring nematodes, nematode, Criconema spp., Criconemella spp., Criconemoides spp., Mesocriconema spp.; stem and rhizome nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus spp.; Awl nematode, Dolichodorus spp.;Spiral nematode, Heliocotylenchus multicinctus and other Helicotylenchus species;Sheath and sheathoid nematode, Hemicycliophora species and Hemicriconemoides species;Hirshmanniella species;Lance nematode, Hoploaimus species;False root-knot nematode, Nacobbus species;Needle nematode, Longidorus elongatus and other Longidorus species;Pin nematode, nematode, Pratylenchus spp.; Lesion nematode, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus spp.; Burrowing nematode, Radopholus similis and other Radopholus spp.; Reniform nematode, Rotylenchus robustus, Rotylenchus reniformis reniformis and other Rotylenchus species; Scutellonema species;plant parasitic nematodes such as the stubby root nematode, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; the stunt nematode, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species; the Citrus nematode, Tylenchulus species; the Dagger nematode, Xiphinema species; and plant parasitic nematodes such as Subanguina spp., Hypsoperine spp. It also relates to a method for controlling attack on plants and plant parts by other plant parasitic nematode species such as Macroposthonia spp., Melinius spp., Punctodera spp. and Quinisulcius spp. In particular, nematode species Meloidogyne spp. (Melodoigyne incognita), Heterodera spp. (Heterodera schachtii), Rotylenchus spp. and Pratylenchus spp. can be controlled by the compounds of the invention;
[0869] The compounds of the present invention may also have activity against mollusks. Examples of mollusks include, for example, the family Ampullariidae; the genus Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus); the family Bradybaenidae (Bradybaena furticum); fruticum); Cepaea (C. hortensis, C. nemoralis); ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum) tum); Discus (D. rotundatus); Euomphalia; Galba (G. trunculata); Helicelia (H. itala, H. obvia); Helicidae Helicigona albustrum arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus); Monoa These include the genera Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); Opeas; Pomacea (P. canaticulata); Vallonia and Zanitoides.
[0870] The term "crop plant" should also be understood to include crop plants that have been transformed by the use of recombinant DNA techniques so as to be capable of synthesizing one or more selectively acting toxins, such as those known to be derived from toxin-producing bacteria, particularly bacteria of the genus Bacillus.
[0871] Toxins which may be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or δ-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, insecticidal proteins from Bacillus thuringiensis or plant insecticidal proteins (Vip), such as Vip1, Vip2, Vip3 or Vip3A; or bacterial-colonizing nematodes, such as Photorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus or Xenorhabdus spp. spp.); toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and neurotoxins specific to other insects; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectin, barley lectin or snowdrop lectin; agglutinins; trypsin inhibitors, serine protease inhibitors, proteinase inhibitors, such as patatin, cystatin, papain inhibitors; ricin, maize-RIP, abrin, rufin, saporin, ribosome-inactivating proteins (RIPs) such as bryodin or bryodin; steroid metabolic enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase and glucanase.
[0872] In the context of the present invention, delta-endotoxins are understood, for example, by Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C or plant insecticidal proteins (Vip), such as Vip1, Vip2, Vip3 or Vip3A, and also specifically by hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by new combinations of different domains of these proteins (see, for example, WO 02 / 15701). Truncated toxins, such as truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the native toxin are replaced. In such amino acid replacements, preferably a non-naturally occurring protease recognition sequence is inserted into the toxin, for example in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into the Cry3A toxin (see, for example, WO 03 / 018810).
[0873] Examples of such toxins or transgenic plants capable of synthesizing such toxins are disclosed, for example, in EP 0 374 753, WO 93 / 07278, WO 95 / 34656, EP 0 427 529, EP 451 878 and WO 03 / 052073.
[0874] Methods for the preparation of such transgenic plants are generally known to those skilled in the art and are described, for example, in the above-mentioned publications. Deoxyribonucleic acids of the CryI type and their preparation are known, for example, from WO 95 / 34656, EP 0 367 474, EP 0 401 979 and WO 90 / 13651.
[0875] The toxins contained in the transgenic plants confer resistance to the plants against pests found in a range of insect taxa, but are most commonly found in beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).
[0876] Transgenic plants containing one or more genes encoding insecticidal resistance and expressing one or more toxins are known, and some of them are commercially available. Examples of such plants are YieldGard® (a corn variety expressing the Cry1Ab toxin); YieldGard Rootworm® (a corn variety expressing the Cry3Bb1 toxin); YieldGard Plus® (a corn variety expressing the Cry1Ab and Cry3Bb1 toxins); Starlink® (a corn variety expressing the Cry9C toxin); Herculex I® (a corn variety expressing the Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) for resistance to the herbicide glufosinate ammonium); NuCOTN 33B® (a cotton variety expressing the Cry1Ac toxin); Bollgard I® (a cotton variety expressing the Cry1Ac toxin); Bollgard II® (a cotton variety expressing Cry1Ac and Cry2Ab toxins); VipCot® (a cotton variety expressing Vip3A and Cry1Ab toxins); NewLeaf® (a potato variety expressing Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate tolerance trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta®.
[0877] Further examples of such transgenic crops are: 1. Bt11 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS (Chemin de l'Hobit 27, F-31 790 St.Sauveur, France). Transgenic maize conferred resistance to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenicly expresses the enzyme PAT to confer tolerance to the herbicide glufosinate ammonium.
[0878] 2. Bt176 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS (Chemin de l'Hobit 27, F-31 790 St.Sauveur, France). Transgenic maize conferred resistance to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of the Cry1Ab toxin. Bt176 maize also transgenicly expresses the enzyme PAT to confer tolerance to the herbicide glufosinate ammonium.
[0879] 3. MIR604 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS (Chemin de l'Hobit 27, F-31 790 St. Sauveur, France). Maize made insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by the insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03 / 018810.
[0880] 4. MON 863 maize, registration number C / DE / 02 / 9, from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. MON 863 expresses the Cry3Bb1 toxin and confers resistance to certain Coleoptera insects.
[0881] 5. IPC 531 cotton, registration number C / ES / 96 / 02, manufactured by Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium.
[0882] 6. 1507 maize, registration number C / NL / 00 / 10, from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium. Genetically modified maize for expression of the protein Cry1F for resistance to certain Lepidoptera insects and the PAT protein for resistance to the herbicide glufosinate ammonium.
[0883] 7. NK603 x MON 810 maize, registration number C / GB / 02 / M3 / 03, from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. It consists of a conventionally bred hybrid maize variety by crossing the genetically modified varieties NK603 and MON 810. NK603 x MON 810 maize also genetically expresses the protein CP4 EPSPS from Agrobacterium sp. strain CP4, which confers resistance to the herbicide Roundup® (containing glyphosate), and the Cry1Ab toxin from Bacillus thuringiensis subsp. kurstaki, which confers resistance to certain Lepidoptera, including the European Corn Borer.
[0884] Transgenic crops of insect-resistant plants are also described in the BATS (Zentrum für Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http: / / bats.ch).
[0885] The term "crop plant" should also be understood to include crop plants that have been transformed by the use of recombinant DNA techniques so as to be able to synthesize antipathogenic substances with selective action, such as, for example, so-called "pathogenicity-related proteins" (PRPs, see, for example, EP-A-0392225). Examples of such antipathogenic substances and transgenic plants capable of synthesizing such antipathogenic substances are known, for example, from EP-A-0392225, WO-A-95 / 33818 and EP-A-0353191. Methods for producing such transgenic plants are generally known to the skilled person and are described, for example, in the above-mentioned publications.
[0886] Crops can also be improved to increase resistance to fungal (e.g., Fusarium, anthracnose or Phytophthora), bacterial (e.g., Pseudomonas) or viral (e.g., Potato Leaf Curl Virus, Tomato Spotted Wilt Virus, Cucumber Mosaic Virus) pathogens.
[0887] Crops also include those that have high resistance to nematodes, such as the soybean cyst nematode.
[0888] Crops that are tolerant to abiotic stress include those that have increased tolerance to drought, high salinity, heat, cold, frost or light due to, for example, expression of NF-YB or other proteins known in the art.
[0889] Anti-pathogenic substances which may be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers of sodium or calcium channels, e.g. viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; so-called "pathogenesis related proteins" (PRPs; see, for example, EP 0 392 225); anti-pathogenic substances produced by microorganisms, such as peptide or heterocyclic antibiotics (see, for example, WO 95 / 33818) or proteins or polypeptide factors involved in plant pathogen defense (so-called "plant disease resistance genes" as described in WO 03 / 000906).
[0890] Further fields of use of the compositions according to the invention are the protection of storehouses and storage rooms and the protection of raw materials (such as wood and textiles), floor coverings and buildings and in the hygiene sector, in particular the protection of humans, livestock and productive livestock from pests of the abovementioned types.
[0891] The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http: / / www.who.int / malaria / vector_control / irs / en / ). In one embodiment, the method for controlling pests comprises applying the composition of the present invention to the target pest, its habitat, or a surface or substrate by brushing, rolling, spraying, painting, or immersion. By way of example, IRS (indoor residual spray) application of surfaces such as walls, ceilings, or floors is contemplated by the method of the present invention. In another embodiment, it is contemplated to apply such compositions to substrates such as nonwoven or woven materials in the form of (or that can be used to manufacture) netting, clothing, bedding, curtains, and tents.
[0892] In one embodiment, the method of controlling such pests comprises applying a pesticidally effective amount of the composition of the present invention to a target pest, its habitat, or a surface or substrate, so as to provide effective residual pest control activity to the surface or substrate. Such application can be performed by brushing, rolling, spraying, painting, or immersing the pesticidal composition of the present invention. By way of example, IRS application on surfaces such as walls, ceilings, or floors is contemplated by the method of the present invention, so as to provide effective residual pest control activity to the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on substrates such as fabric materials in the form of (or that can be used to manufacture) netting, clothing, bedding, curtains, and tents.
[0893] The substrates to be treated, including nonwovens, fabrics or nets, can be made of natural fibers such as cotton, raffia, jute, flax, sisal, hemp or wool, or synthetic fibers such as polyamide, polyester, polypropylene, polyacrylonitrile. Polyesters are particularly suitable. Methods of textile treatment are known, for example, from WO 2008 / 151984, WO 2003 / 034823, US 5631072, WO 2005 / 64072, WO 2006 / 128870, EP 1724392, WO 2005113886 or WO 2007 / 090739.
[0894] A further field of use for the compositions according to the invention is that of trunk injection / trunk treatment of all ornamental trees and of all kinds of fruit and nut-bearing trees.
[0895] In the field of trunk injection / trunk treatment, the compounds according to the invention are particularly suitable against wood-boring insects of the abovementioned orders Lepidoptera and Coleoptera, in particular against the woodborers listed in Tables A and B below.
[0896] [Table 3]
[0897] [Table 4-1] [Table 4-2] [Table 4-3]
[0898] The present invention may also be used to control any insect pest that may be present in turfgrass, including, for example, beetles, caterpillars, fire ants, ground pearls, millipedes, pillbugs, mites, mole crickets, scale insects, mealybugs, mites, foxtails, southern chinch bugs, and grubs. The present invention may be used to control insect pests in various stages of their life cycle, including eggs, larvae, nymphs, and adults.
[0899] In particular, the present invention relates to the prevention and treatment of earthworms (Cyclocephala spp. (e.g. masked chafer, C. lurida), Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp. (e.g. blue swallowtail beetle, C. nitida), Popillia spp. (e.g. Japanese beetle, P. japonica), Phyllophaga spp. (e.g. May / June beetle), Ataenius spp. (e.g. cephalosporinus, C. spp.), and the like). spp. (e.g. Black turfgrass ataenius, A. spretulus), Maladera spp. (e.g. red-veined beetle, M. castanea) and Tomarus spp.), cotton scales (Margarodes spp.), mole crickets (tawny, southern and brachypterous; Scapteriscus spp., Gryllotalpa africana) and leatherjackets (European crane fly, Tipula The present invention may be used to control insect pests that feed on the roots of turfgrass, including Pseudomonas spp.
[0900] The present invention may also be used to control straw-dwelling insect pests of turfgrass, including cutworms (such as Spodoptera frugiperda and the common armyworm (such as Pseudaletia unipuncta), cutworms, weevils (such as Sphenophorus spp., S. venatus verstitus and S. parvulus) and sod webworms (such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis).
[0901] The present invention may also be used to control insect pests that live above ground and feed on turfgrass leaves, including the lesser stink bug (such as the southern kinkbug, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug (Propsapia bicincta), leafhoppers, cutworms (Noctuidae), and greenbugs.
[0902] The present invention may also be used to control other pests of turfgrass, such as the red fire ant (Solenopsis invicta), which creates ant mounds in turfgrass.
[0903] In the hygiene field, the compositions according to the invention are effective against ectoparasites such as hard ticks, soft ticks, scabies mites, chiggers, flies (stable flies and licking flies), parasitic fly larvae, lice, pubic lice, bite lice and fleas.
[0904] Examples of such parasites are: From the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.
[0905] From the order Mallophagida: the genera Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp.
[0906] Among the order Diptera and its suborders Nematocerina and Brachycerina, for example, the genera Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., spp.), Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp. spp.), Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipotena spp. and Melophagus spp.
[0907] Among the order Siphonapterida, for example, the genera Pulex spp., Ctenocephalides spp., Xenopsylla spp., and Ceratophyllus spp.
[0908] From the order Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp.
[0909] From the order Blattaridae, for example, Blatta orientalis, Periplaneta americana, Blattela germanica and Supella spp.
[0910] Among the subclass Acaria (Acarida) and the suborders Metastigmata and Mesostigmata, for example, the genera Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., spp.), Pneumonyssus spp., Sternostoma spp. and Varroa spp.
[0911] Among the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example, the genera Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., spp.), Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.
[0912] The compositions according to the invention are also suitable for protecting against insect infestation in materials such as wood, textiles, plastics, adhesives, glues, paints, paper and cardboard, leather, floor coverings and building materials.
[0913] The compositions according to the invention can be used, for example, against the following pests: Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec., Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec.and Dinoderus minutus, as well as hymenopteran insects such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, and Urocerus augur, as well as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, and other insects of the genus Cyperus. Termites such as Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, and woodworms such as Lepisma saccharina.
[0914] The compounds according to the present invention can be used as pesticides in unmodified form, but they are generally formulated into compositions in various ways using formulation aids such as carriers, solvents and surfactants. The formulations can be in various physical forms, such as dusts, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-based flowables, aqueous dispersions, oil-based dispersions, suspoemulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (containing water or water-miscible organic solvents as carriers), impregnated polymer films or other forms known, for example, from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010). Such formulations can be used directly or diluted before use. Dilution can be carried out, for example, with water, liquid fertilizers, micronutrients, biological organisms, oils or solvents.
[0915] The formulations can be prepared, for example, by mixing the active ingredient with formulation auxiliaries to obtain a composition in the form of a finely divided solid, granules, liquid, dispersion or emulsion. The active ingredient can also be formulated with other auxiliaries, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
[0916] The active ingredient may be contained in fine microcapsules. The microcapsules also contain the active ingredient in a porous carrier. This allows the active ingredient to be released in controlled amounts into the environment (e.g., sustained release). The microcapsules usually have a diameter of 0.1 to 500 μm. The microcapsules contain the active ingredient in an amount of about 25 to 95% by weight of the capsule weight. The active ingredient may be in the form of a monolithic solid, in the form of fine particles in a solid or liquid dispersion, or in the form of a suitable solution. The encapsulating membrane may, for example, comprise natural or synthetic rubber, cellulose, styrene / butadiene copolymer, polyacrylonitrile, polyacrylate, polyester, polyamide, polyurea, polyurethane or chemically modified polymers and starch xanthate or other polymers known to those skilled in the art. Alternatively, fine microcapsules may be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of the base, but the microcapsules themselves are not encapsulated.
[0917] The formulation auxiliaries suitable for the preparation of the compositions according to the invention are known per se.As liquid carriers, the following may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-Trichloroethane, 2-heptanone, α-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid carboxylic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, etc.,
[0918] Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed hulls, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar materials.
[0919] Many surface-active substances can be used advantageously in both solid and liquid formulations, especially in formulations which may be diluted with a carrier before use. Surface-active substances can be anionic, cationic, nonionic or polymeric and they can be used as emulsifying agents, wetting agents or suspending agents or for other purposes. Typical surface-active materials include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide adducts, such as nonylphenol ethoxylate; alcohol / alkylene oxide adducts, such as tridecyl alcohol ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinates, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and di-alkyl phosphate esters; and further materials, such as those described in, for example, McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981).
[0920] Further auxiliaries which may be used in the pesticide formulations include crystallization inhibitors, viscosity modifiers, suspending agents, dyes, antioxidants, foaming agents, light absorbers, mixing aids, defoamers, complexing agents, neutralizing or pH adjusting substances and buffers, corrosion inhibitors, fragrances, wetting agents, absorption enhancers, micronutrients, plasticizers, glidants, lubricants, dispersants, thickeners, antifreeze agents, fungicides and liquid and solid fertilizers.
[0921] The composition according to the invention may contain an additive comprising an oil of vegetable or animal origin, a mineral oil, an alkyl ester of such an oil or a mixture of such an oil and an oil derivative. The amount of the oil additive in the composition according to the invention is generally 0.01-10% based on the mixture to be applied. For example, the oil additive may be added to the spray tank in the desired concentration after the spray mixture is prepared. Preferred oil additives include mineral oil or oil of vegetable origin, such as rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl ester of oil of vegetable origin, such as methyl derivatives, or oil of animal origin, such as fish oil or beef tallow. Preferred oil additives are C 8 ~C 22 Alkyl esters of fatty acids, especially C 12 ~C 18 Methyl derivatives of fatty acids, such as the methyl esters of lauric acid, palmitic acid, and oleic acid (methyl laurate, methyl palmitate, and methyl oleate, respectively). Many oil derivatives are described in the Compendium of Herbicide Adjuvants, 10 th Edition, Southern Illinois University, 2010.
[0922] The compositions of the invention generally comprise 0.1-99% by weight, in particular 0.1-95% by weight, of the compound of the invention and 1-99.9% by weight of formulation auxiliaries, which preferably comprise 0-25% by weight of surface-active substances. Commercial products may preferably be formulated as concentrates, but end users will usually employ dilute formulations.
[0923] The application rates vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pests to be controlled, the prevailing climatic conditions and other factors which depend on the method of application, the time of application and the target crop. As a general guideline, the compounds may be applied at a rate of 1 to 2000 l / ha, in particular 10 to 1000 l / ha.
[0924] A preferred formulation may have the following composition (by weight): Emulsifiable concentrate: Active ingredient: 1-95%, preferably 60-90% Surfactant: 1-30%, preferably 5-20% Liquid carrier: 1-80%, preferably 1-35%
[0925] Dust agent: Active ingredient: 0.1-10%, preferably 0.1-5% Solid carrier: 99.9 to 90%, preferably 99.9 to 99%
[0926] Suspension concentrates: Active ingredient: 5-75%, preferably 10-50% Water: 94-24%, preferably 88-30% Surfactant: 1-40%, preferably 2-30%
[0927] Wettable powder: Active ingredient: 0.5-90%, preferably 1-80% Surfactant: 0.5-20%, preferably 1-15% Solid carrier: 5 to 95%, preferably 15 to 90%
[0928] Granules: Active ingredient: 0.1-30%, preferably 0.1-15% Solid carrier: 99.5 to 70%, preferably 97 to 85%
[0929] The following examples further illustrate the present invention without, however, limiting it.
[0930] [Table 5]
[0931] This combination is thoroughly mixed with the adjuvant and the mixture is thoroughly ground in a suitable mill to obtain a wettable powder, which is diluted with water to obtain a suspension of the desired concentration.
[0932] [Table 6]
[0933] This combination is thoroughly mixed with an adjuvant and the mixture thoroughly ground in a suitable mill to obtain a dust which can be used directly as a seed treatment.
[0934] [Table 7]
[0935] Emulsifiable concentrates of any desired dilution which can be used for plant protection are obtained from this concentrate by dilution with water.
[0936] [Table 8]
[0937] Ready-to-use dusts are obtained by combining and mixing with a carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressing of seeds.
[0938] [Table 9]
[0939] This combination is mixed with an auxiliary agent, ground, the mixture is moistened with water, the mixture is extruded and then dried in a stream of air.
[0940] [Table 10]
[0941] This micronized combination is applied uniformly in a mixer to kaolin moistened with polyethylene glycol, thus obtaining dust-free coated granules.
[0942] [Table 11]
[0943] This micronized combination is intimately mixed with an adjuvant to obtain a suspension concentrate from which suspensions of any desired dilution are obtained by dilution with water, with which living plants as well as plant propagation material can be treated and protected from microbial infestation by spraying, pouring or immersion.
[0944] [Table 12]
[0945] This micronized combination is intimately mixed with an adjuvant to obtain a suspension concentrate from which suspensions of any desired dilution are obtained by dilution with water, with which living plants as well as plant propagation material can be treated and protected from microbial infestation by spraying, pouring or immersion.
[0946] Sustained Release Capsule Suspension 28 parts of this combination are mixed with 2 parts of aromatic solvent and 7 parts of toluene diisocyanate / polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of antifoaming agent and 51.6 parts of water until the desired particle size is obtained. A mixture of 2.8 parts of 1,6-diaminohexane in 5.3 parts of water is added to this emulsion. The mixture is stirred until the polymerization reaction is complete. The resulting capsule suspension is stabilized by adding 0.25 parts of thickener and 3 parts of dispersant. The capsule suspension formulation contains 28% active ingredient. The capsules have a median diameter of 8-15 μm. The resulting formulation is applied to the seeds as an aqueous suspension in a device suitable for the purpose in question.
[0947] Formulation types include emulsifiable concentrates (EC), suspension concentrates (SC), suspoemulsions (SE), capsule suspensions (CS), wettable granules (WG), emulsifiable granules (EG), water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil-miscible flowables (OF), oil-miscible liquids (OL), soluble concentrates (SL), suspension concentrates for microdispersion (SU), liquid concentrates for microdispersion (UL), technical concentrates (TK), dispersible concentrates (DC), wettable powders (WP), soluble granules (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants. EXAMPLES
[0948] Preparation Example: "Mp" means melting point (° C.). The free radical represents a methyl group. 1 H NMR measurements were recorded on a Brucker 400 MHz spectrometer and chemical shifts are given in ppm relative to TMS standard. Spectra were measured in deuterated solvents as indicated. Compounds were characterized using one of the following LCMS methods. Characteristic LCMS values obtained for each compound are retention time ("Rt", recorded in minutes) and observed molecular ion (M+H). + or (MH) - It was.
[0949] LCMS method: Method 1: Spectra were recorded on a Waters mass spectrometer (SQD single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive or negative ion, full scan, capillary: 3.00 kV, cone range: 41 V, source temperature: 150° C., desolvation temperature: 500° C., cone gas flow: 50 L / Hr, desolvation gas flow: 1000 L / Hr, mass range: 110-800 Da) and a Waters H-class UPLC: binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3 C18, 1.8 μm, 30 × 2.1 mm, Temperature: 40 °C, DAD waveband (nm): 210-400, Solvent gradient: A = water + 5% acetonitrile + 0.1% HCOOH, B = acetonitrile + 0.05% HCOOH: Gradient: 0 min, 10% B; 0.-0.2 min, 10% to 50% B; 0.2-0.7 min, 50% to 100% B; 0.7-1.3 min, 100% B; 1.3-1.4 min, 100% to 10% B; 1.4-1.6 min, 10% B; Flow (mL / min) 0.6.
[0950] Method 2: Spectra were recorded on an Agilent Technologies mass spectrometer (6410 Triple Quadrupole mass spectrometer) equipped with: electrospray source (polarity: positive or negative ion, MS2 scan, capillary: 4.00 kV, fragmentor: 100 V, stripping temperature: 350° C., gas flow: 11 L / min, nebulizer gas: 45 psi, mass range: 110-1000 Da) and an Agilent 1200 Series HPLC: quaternary pump, heated column compartment and diode-array detector. Column: KINETEX EVO C18, 2.6 μm, 50 × 4.6 mm, Temperature: 40 °C, DAD wavelength range (nm): 210-400, Solvent gradient: A = water + 5% acetonitrile + 0.1% HCOOH, B = acetonitrile + 0.1% HCOOH: Gradient: 0% B for 0 min, 100% A; 100% B for 0.9-1.8 min; 100% to 10% B for 1.8-2.2 min; 10% B for 2.2-2.5 min; Flow (mL / min) 1.8.
[0951] Example P1: [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 Preparation of -sulfane (compound P1) [ka] Step 1: Preparation of 5-bromo-3-ethylsulfonyl-N-[2-hydroxy-5-(trifluoromethylsulfanyl)phenyl]pyridine-2-carboxamide (Intermediate I1) [ka] To a 0° C. cooled suspension of 5-bromo-3-ethylsulfonyl-pyridine-2-carboxylic acid (CAS 2098699-89-7, prepared as described in WO2018215304) (5.3 g, 18 mmol) in dichloromethane (53 mL) and DMF (1.8 mL), oxalyl dichloride (3.2 mL, 36 mmol) was added dropwise via syringe. The off-white suspension thus obtained was stirred at room temperature for 2 hours. The reaction mass was evaporated to dryness under nitrogen atmosphere to give crude 5-bromo-3-ethylsulfonyl-pyridine-2-carbonyl chloride, which was used as such for the next step.
[0952] To a 0° C. cooled solution of 2-amino-4-(trifluoromethylsulfanyl)phenol (CAS 228401-48-7, prepared as described in WO2011040629) (4.5 g, 21 mmol) in tetrahydrofuran (20 mL) was added N,N-diisopropylethylamine (6.1 mL, 36 mmol) followed by freshly prepared solution of 5-bromo-3-ethylsulfonyl-pyridine-2-carbonyl chloride in THF (20 mL). The reaction mass was stirred at room temperature for 16 hours then quenched with water (100 mL) and extracted with ethyl acetate (3×80 mL). The combined organic layers were washed with brine (100 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The crude compound was purified using combiflash (silica gel, 10-15% ethyl acetate in cyclohexane) to give 5-bromo-3-ethylsulfonyl-N-[2-hydroxy-5-(trifluoromethyl-sulfanyl)phenyl]pyridine-2-carboxamide. LCMS (Method 1): Retention time 1.11 min, 485 (M+H) + .
[0953] Step 2: Preparation of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfanyl)-1,3-benzoxazole (Intermediate I2) [ka] To a stirred solution of 5-bromo-3-ethylsulfonyl-N-[2-hydroxy-5-(trifluoromethylsulfanyl)phenyl]pyridine-2-carboxamide (intermediate I1 prepared as above) (4.5 g, 9.3 mmol) in m-xylene (45 mL) was added 4-methylbenzenesulfonic acid hydrate (1.6 g, 9.3 mmol) at room temperature and the reaction mass was heated at 160 °C for 9 h. The reaction mixture was cooled to room temperature, diluted with water (50 mL) and extracted with ethyl acetate (3 x 50 mL). The combined organic layers were washed with brine (50 mL), dried over sodium sulfate, filtered and concentrated in vacuum. The crude compound was purified using combiflash (silica gel, 10-15% ethyl acetate in cyclohexane) to give 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfanyl)-1,3-benzoxazole. LCMS (Method 1): Retention time 1.23 min, 476(M+H) + 1H NMR (400MHz, DMSO-d 6 )δ ppm 1.28(t,3H),3.91-3.98(m,2H),7.91(dd,1H),8.10(d,1H),8.38(d,1H),8.74(d,1H),9.30(d,1H).
[0954] Step 3: [5-Ethylsulfonyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]-3-pyridyl]imino-dimethyl-oxo-λ 6 -Preparation of sulfane (intermediate I3) [ka] To a solution of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfanyl)-1,3-benzoxazole (intermediate I2 prepared as above) (0.59 g, 1.26 mmol) in 1,4-dioxane (5.0 mL) was added (dimethanesulfinylidene)amine (0.136 g, 1.38 mmol), cesium carbonate (0.827 g, 2.52 mmol) and (5-diphenylphosphanyl-9,9-dimethyl-xanthen-4-yl)-diphenyl-phosphane (0.15 g, 0.25 mmol). The reaction mass was degassed with nitrogen for 10 minutes, followed by the addition of (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium (0.11 g, 0.12 mmol). The reaction mass was refluxed at 110° C. under nitrogen atmosphere for 3 hours, then diluted with water (30 mL) and extracted with ethyl acetate (3×30 mL). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuum. The crude product was purified by combiflash (silica gel, 10% methanol in dichloromethane) and purified as [[5-ethylsulfonyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]-3-pyridyl]imino-dimethyl-oxo-λ 6 Sulfane was obtained. LCMS (Method 1): Retention time 1.05 min, 480 (M+H) + . 1 H NMR (400 MHz, chloroform-d) δ ppm 1.44 (t, 3H), 3.32 (s, 6H), 4.05 (q, 2H), 7.68-7.75 (m, 2H), 8.14-8.18 (m, 2H), 8.70 (d, 1H).
[0955] Step 4: [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 Preparation of -sulfane (compound P1) [ka] Stirred [[5-ethylsulfonyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]-3-pyridyl]imino-dimethyl-oxo-λ 6 A solution of 1.0-sulfane (intermediate I3 prepared as above) (0.4 g, 0.83 mmol) in 2,2,3,3,4,4,5,5-octafluoropentan-1-ol (7.0 mL) was treated with ammonium carbamate (0.19 g, 2.5 mmol) followed by PhI(OAc). 2 (1.15 g, 3.5 mmol) was added at room temperature. The reaction mixture was stirred at room temperature for 6 h. The reaction mass was quenched with ice-cold water (20 mL) and extracted with ethyl acetate (3×20 mL). The combined organic layers were washed with sodium thiosulfate solution (20 mL) and brine (20 mL), dried over sodium sulfate, filtered and concentrated in vacuum. The crude product was purified by combiflash (silica gel, 10% MeOH in dichloromethane) to give [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -sulfane was obtained. LCMS (Method 1): Retention time 0.91 min, 511 (M+H) + . 1H NMR (400MHz, acetone-d 6 )δ ppm 1.32-1.41(m,3H),3.49(s,6H),3.94(q,2H),8.05(d,1H),8.16(d,1H),8.32(d,1H),8.32(d,1H),8.58-8.63(m,2H).
[0956] Example P2: [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-λ 6 Preparation of -sulfane (compound P2) [ka] Step 1: [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -Preparation of sulfane (intermediate I4) [ka] To a stirred solution of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-5-(trifluoromethylsulfanyl)-1,3-benzoxazole (intermediate I2 prepared as above) (0.9 g, 1.92 mmol) in 2,2,3,3,4,4,5,5-octafluoropentan-1-ol (12.0 mL) was added ammonium carbamate (0.46 g, 5.77 mmol), followed by PhI(OAc). 2 (2.65 g, 8.09 mmol) was added at room temperature. The reaction mixture was stirred at room temperature for 16 hours. The reaction mass was quenched with ice cold water (50 mL) and extracted with ethyl acetate (3×50 mL). The combined organic layers were washed with sodium thiosulfate solution (50 mL) and brine (50 mL), dried over sodium sulfate, filtered and concentrated in vacuum. The crude product was purified by combiflash (silica gel, 40% ethyl acetate in cyclohexane) and purified with [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -Sulfane was obtained. LCMS (Method 1): Retention time 1.05 min, 498 (M+H) + .
[0957] Step 2: [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-λ 6 -Preparation of sulfane (intermediate I5) [ka] Stirred [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda6 To a solution of 1.5 g, 3.0 mmol of 2-sulfane (intermediate I4 prepared as above) in N,N-dimethylformamide (15.0 mL) was added potassium carbonate (1.2 g, 9.0 mmol) followed by iodoethane (700 mg, 4.5 mmol). The reaction mass was stirred at room temperature for 4 h and then quenched with ice-cold water (80 mL) and extracted with ethyl acetate (3×50 mL). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuum. The crude product was purified by combiflash (silica gel, 40% ethyl acetate in cyclohexane) and purified as [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda. 6 -Sulfane was obtained. LCMS (Method 1): Retention time 1.21 min, 526(M+H) + .
[0958] Step 3: [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-λ 6 Preparation of -sulfane (compound P2) [ka] [2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6To a solution of 1,4-dioxane (intermediate I5 prepared as above) (0.70 g, 1.33 mmol) in 1,4-dioxane (5.0 mL) was added (dimethanesulfinylidene)amine (0.14 g, 1.46 mmol), cesium carbonate (0.87 g, 2.66 mmol) and (5-diphenylphosphanyl-9,9-dimethyl-xanthen-4-yl)-diphenyl-phosphane (0.15 g, 0.26 mmol). The reaction mass was degassed with nitrogen for 10 minutes, followed by the addition of (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium (0.12 g, 0.13 mmol). The reaction mass was refluxed at 110° C. under nitrogen atmosphere for 3 hours, then diluted with water (30 mL) and extracted with ethyl acetate (3×30 mL). The combined organic layers were dried over sodium sulfate, filtered and concentrated in vacuo. The crude product was purified by combiflash (silica gel, 10% methanol in dichloromethane) to give [2-[5-[[dimethyl(oxo)-λ 6 -Sulfanilidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-λ 6 -sulfane was obtained as a white solid. LCMS (Method 1): Retention time 1.07 min, 539 (M+H). + 1H NMR (400MHz, chloroform-d) δ ppm 1.31-1.38(m,3H), 1.43-1.48(m,3H), 3.33(s,6H), 3.39-3.63(m,1H), 3.40-3.61(m,1H), 3.96-4.08(m,2H), 7.79-7.92(m,1H), 8.13-8.22(m,2H), 8.50-8.71(m,2H).
[0959] Example P3: Preparation of N-[5-ethylsulfonyl-6-[5-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-3-pyridyl]-N-methyl-acetamide (compound P3) [ka] Step 1: Preparation of tert-butyl 5-bromo-3-ethylsulfanyl-pyridine-2-carboxylate (Intermediate I6) [ka] 4-Dimethylaminopyridine (0.23 g, 0.19 mmol) and di-tert-butyl dicarbonate (6.31 g, 28.6 mmol) were added to a solution of 5-bromo-3-ethylsulfanyl-pyridine-2-carboxylic acid (CAS 1857366-13-2, prepared as described in WO2017084879) (5.00 g, 19.1 mmol) in acetonitrile (100 mL) with triethylamine (4.03 mL, 28.6 mmol). The reaction mixture was heated at 50 °C overnight. After cooling to room temperature, the reaction mixture was diluted with water (80 mL) and the aqueous phase was extracted with ethyl acetate (3 x 100 mL). The combined organic phases were dried over sodium sulfate, filtered and concentrated in vacuo. The resulting crude oil was purified by flash chromatography on silica gel (35% ethyl acetate in cyclohexane) to give the desired compound as a yellow oil. 1 H NMR(400MHz,chloroform-d)δ ppm:1.39-1.45(m,3H),1.65(s,9H),2.92(q,J=7.34Hz,2H),7.75(d,J=1.96Hz,1H),8.45(d...
Claims
1. Formula (I) 【Chemistry 1】 (In the formula, G 1 and G 2 are, independently of each other, CH or N; G 3 is NCH 3 or O; R 1 is C 1 ~C 6 Alkyl or C 1 ~C 6 haloalkyl; R 2 is H, C 1 ~C 6 Alkyl, C 1 ~C 6 Cycloalkyl, C 1 ~C 6 Haloalkyl, —C(O)R 3 or CN; R 3 is C 1 ~C 6 is alkyl; Q is a group of the formula Qa and Qb 【Chemistry 2】 where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A is CH or N; X is S, SO or SO 2 and R 4 is C 1 ~C 4 is alkyl; R 5 is hydrogen or halogen; or R 5 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to the ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and said ring system can contain 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where said ring system cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; or R 5 is a 5-membered aromatic ring system linked via a ring nitrogen atom to the ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and said ring system contains 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, wherein said ring system contains at least one ring nitrogen atom and cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; R 6 is halogen, C 1 ~C 6 Haloalkyl, C 3 ~C 6 Cycloalkyl, C monosubstituted by cyano 3 ~C 6 Cycloalkyl, C monosubstituted by cyano 3 ~C 6 Alkyl, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, cyano substituted C 1 ~C 6 Alkoxy, -N=S(O)R 7 R 8 , N(R 9 ) C(=O)R 10 , N(R 11 ) R 12 or 2-pyridyloxy; or R 6 is a 5- to 6-membered aromatic ring system linked via a ring carbon atom to the ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and said ring system can contain 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, where said ring system cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; or R 6 is a 5-membered aromatic ring system linked via a ring nitrogen atom to the ring containing the substituent A, said ring system being unsubstituted or substituted with halogen, cyano, C 1 ~C 4 Alkyl, C 1 ~C 4 Haloalkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkoxy, C 1 ~C 4 Alkylsulfanyl, C 1 ~C 4 Alkylsulfinyl and C 1 ~C 4 alkylsulfonyl; and said ring system contains 1, 2 or 3 ring heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, wherein said ring system contains at least one ring nitrogen atom and cannot contain more than one ring oxygen atom and cannot contain more than one ring sulfur atom; R 7 and R 8 are, independently of each other, C 1 ~C 6 is alkyl; R 9 is H or C 1 ~C 6 is alkyl; R 10 is C 1 ~C 6 Alkyl or C 3 ~C 6 is cycloalkyl; R 11 and R 12 are each independently H or C 1 ~C 6 is alkyl) or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide of a compound of formula I.
2. Formula I-1 【Chemistry 3】 (In the formula, G 1 , G 2 , R 1 , R 2 , A, X, R 4 and R 5 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
3. Formula I-2 【Chemistry 4】 (In the formula, G 1 , G 2 , R 1 , R 2 , A, X, R 4 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
4. Formula I-3 【Chemistry 5】 (In the formula, G 1 , G 2 , R 1 , R 2 , A, X, R 4 and R 5 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
5. Formula I-4 【Chemistry 6】 (In the formula, G 1 , G 2 , R 1 , R 2 , A, X, R 4 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
6. Formula I-5 【Chemistry 7】 (In the formula, R 1 , R 2 , A, X, R 4 and R 5 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
7. Formula I-6 【Chemistry 8】 (In the formula, R 1 , R 2 , A, X, R 4 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
8. Formula I-7 【Chemistry 9】 (In the formula, R 1 , R 2 , A, X, R 4 and R 5 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
9. Formula I-8 【Chemistry 10】 (In the formula, R 1 , R 2 , A, X, R 4 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
10. R 1 is methyl or trifluoromethyl; preferably trifluoromethyl; X is S or SO 2 ; preferably SO 2 and R 4 is C 1 ~C 2 A compound according to any one of claims 1 to 9, which is alkyl; preferably ethyl.
11. Formula I-9 【Chemistry 11】 (wherein Q is a group represented by the formula Qa1 and Qb1 【Chemistry 12】 where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; R 2 , R 5 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
12. Formula I-10 【Chemistry 13】 (In the formula, R 1 , R 2 , A, X, R 4 and R 5 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
13. Formula I-11 【Chemistry 14】 (In the formula, R 1 , R 2 , A, X, R 4 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
14. Formula I-12 【Chemistry 15】 (In the formula, R 2 is as defined in formula I in claim 1, and Q is of formula Qa1 and Qb1 【Chemistry 16】 where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; R 5 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
15. Formula I-13 【Chemistry 17】 (In the formula, R 2 is as defined in formula I in claim 1, and Q is of formula Qa1 and Qb1 【Chemistry 18】 where the arrow indicates the point of attachment to a carbon atom of the bicyclic ring; A, R 5 and R 6 is as defined in formula I in claim 1.
2. The compound of formula I according to claim 1, represented by the compound: or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
16. R 2 is H, C 1 ~C 4 Alkyl, cyclopropyl, C 1 ~C 4 Haloalkyl, —C(O)R 3 or cyano; preferably, R 2 is H, cyano, methyl, ethyl, cyclopropyl or 2,2,2-trifluoroethyl; and R 3 is C 1 ~C 4 A compound according to any one of claims 1 to 15, which is alkyl; preferably methyl.
17. R 5 is hydrogen, N-linked pyrazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, C-linked pyrimidinyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl, or N-linked triazolyl which may be unsubstituted or monosubstituted by chloro or trifluoromethyl.
18. R 6 is cyclopropyl, 1-cyanocyclopropyl, 2,2,2-trifluoroethoxy, 2,2-difluoropropoxy, 1-cyano-1-methyl-ethoxy, -N=S(O)(CH 3 ) 2 , -N(CH 3 ) COCH 3 , 2-pyridyloxy, pyrimidin-2-yl, 4-trifluoromethyl-pyrimidin-2-yl, 5-cyano-pyrimidin-2-yl, 5-chloro-pyrimidin-2-yl, 3-chloro-pyrazol-1-yl or 3-trifluoromethyl-pyrazol-1-yl.
19. The compound according to any one of claims 1 to 18, wherein A is N.
20. The compound according to any one of claims 1 to 18, wherein A is CH.
21. [2-[5-[[dimethyl(oxo)-λ 6 -sulfanylidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P1); [2-[5-[[dimethyl(oxo)-λ 6 -sulfanylidene]amino]-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P2); N-[5-ethylsulfonyl-6-[5-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-3-pyridyl]-N-methyl-acetamide (compound P3); N-[5-ethylsulfonyl-6-[5-(trifluoromethylsulfonimidoyl)-1,3-benzoxazol-2-yl]-3-pyridyl]-N-methyl-acetamide (compound P4); Ethylimino-[2-[3-ethylsulfonyl-5-[3-(trifluoromethyl)pyrazol-1-yl]-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P5); [2-[3-ethylsulfonyl-5-[3-(trifluoromethyl)pyrazol-1-yl]-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P6); 1-[5-ethylsulfonyl-6-[5-(trifluoromethylsulfonimidoyl)-1,3-benzoxazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P7); 1-[5-ethylsulfonyl-6-[5-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P8); [2-[3-ethylsulfonyl-5-(2-pyridyloxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -Sulfane (compound P9); Ethylimino-[2-[3-ethylsulfonyl-5-(2-pyridyloxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P10); [2-(5-cyclopropyl-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P11); [2-(5-cyclopropyl-3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P12); Cyclopropylimino-[2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P13); [2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(2,2,2-trifluoroethylimino)-(trifluoromethyl)-λ 6 -sulfane (compound P14); [[2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfanylidene]cyanamide (compound P15); [2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P16); N-[[2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfanylidene]acetamide (compound P17); [2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-methylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P18); Ethylimino-[2-(3-ethylsulfonyl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P19); 1-[5-Ethylsulfonyl-6-[6-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-3-methyl-imidazo[4,5-b]pyridin-2-yl]-3-pyridyl]cyclopropane-carbonitrile (compound P20); 1-[5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl-sulfonimidoyl)imidazo[4,5-b]pyridin-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P21); Ethylimino-[2-[3-ethylsulfonyl-5-(2,2,2-trifluoroethoxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P22), [2-[3-ethylsulfonyl-5-(2,2,2-trifluoroethoxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P23), N-[[2-[3-ethylsulfonyl-5-(2,2,2-trifluoroethoxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfanylidene]acetamide (compound P24), N-[[2-[3-ethylsulfonyl-5-(2-pyridyloxy)-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-λ 6 -sulfanylidene]acetamide (compound P25), [2-[5-(2,2-difluoropropoxy)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-λ 6 -sulfane (compound P26), [2-[5-(2,2-difluoropropoxy)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P27), 1-[5-ethylsulfonyl-6-[5-[N-(2,2,2-trifluoroethyl)-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P28), 1-[5-ethylsulfonyl-6-[5-[N-methyl-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P29), 1-[6-[5-[N-cyclopropyl-S-(trifluoromethyl)sulfonimidoyl]-1,3-benzoxazol-2-yl]-5-ethylsulfonyl-3-pyridyl]cyclopropanecarbonitrile (compound P30), 1-[6-[5-[N-cyclopropyl-S-(trifluoromethyl)sulfonimidoyl]-1-methyl-benzimidazol-2-yl]-5-ethylsulfonyl-3-pyridyl]cyclopropanecarbonitrile (compound P31), 1-[5-ethylsulfonyl-6-[5-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-1-methyl-benzimidazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P32), 1-[5-ethylsulfonyl-6-[1-methyl-5-(trifluoromethylsulfonimidoyl)benzimidazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P33), 1-[5-ethylsulfonyl-6-[1-methyl-5-[N-(2,2,2-trifluoroethyl)-S-(trifluoromethyl)sulfonimidoyl]benzimidazol-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P34), Ethylimino-[2-(3-ethylsulfonyl-5-pyrimidin-2-yl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P35), [2-(3-ethylsulfonyl-5-pyrimidin-2-yl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P36), [2-[5-(3-chloropyrazol-1-yl)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P37), [2-[5-(3-chloropyrazol-1-yl)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P38), Ethylimino-[2-[3-ethylsulfonyl-6-(1,2,4-triazol-1-yl)-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P39), [2-[3-ethylsulfonyl-5-[4-(trifluoromethyl)pyrimidin-2-yl]-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P40), Ethylimino-[2-[3-ethylsulfonyl-5-[4-(trifluoromethyl)pyrimidin-2-yl]-2-pyridyl]-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P41), [2-[5-(5-chloropyrimidin-2-yl)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P42), [2-[5-(5-chloropyrimidin-2-yl)-3-ethylsulfonyl-2-pyridyl]-1,3-benzoxazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P43), [2-[3-ethylsulfonyl-6-(1,2,4-triazol-1-yl)-2-pyridyl]-1-methyl-benzimidazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P44), Ethylimino-[2-[3-ethylsulfonyl-6-(1,2,4-triazol-1-yl)-2-pyridyl]-1-methyl-benzimidazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P45), [2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridyl]-1-methyl-benzimidazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P46), [2-[6-(3-chloro-1,2,4-triazol-1-yl)-3-ethylsulfonyl-2-pyridyl]-1-methyl-benzimidazol-5-yl]-ethylimino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P47), [2-[3-ethylsulfonyl-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]-2-pyridyl]-1-methyl-benzimidazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P48), Ethylimino-[2-[3-ethylsulfonyl-6-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]-2-pyridyl]-1-methyl-benzimidazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P49), [2-[3-ethylsulfonyl-5-(2-pyridyloxy)-2-pyridyl]-1-methyl-benzimidazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P50), Ethylimino-[2-[3-ethylsulfonyl-5-(2-pyridyloxy)-2-pyridyl]-1-methyl-benzimidazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P51), 2-[5-ethylsulfonyl-6-[1-methyl-5-(trifluoromethylsulfonimidoyl)benzimidazol-2-yl]-3-pyridyl]pyrimidine-5-carbonitrile (compound P52), 2-[5-ethylsulfonyl-6-[5-[N-ethyl-S-(trifluoromethyl)sulfonimidoyl]-1-methyl-benzimidazol-2-yl]-3-pyridyl]pyrimidine-5-carbonitrile (compound P53), [2-(3-ethylsulfonyl-6-pyrimidin-2-yl-2-pyridyl)-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P54), Ethylimino-[2-(3-ethylsulfonyl-6-pyrimidin-2-yl-2-pyridyl)-1,3-benzoxazol-5-yl]-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P55), [2-[3-ethylsulfonyl-6-(1,2,4-triazol-1-yl)-2-pyridyl]-1,3-benzoxazol-5-yl]-imino-oxo-(trifluoromethyl)-lambda 6 -sulfane (compound P56), 1-[5-ethylsulfonyl-6-[3-methyl-6-[N-(2,2,2-trifluoroethyl)-S-(trifluoromethyl)sulfonimidoyl]imidazo[4,5-b]pyridin-2-yl]-3-pyridyl]cyclopropanecarbonitrile (compound P57), 1-[6-[6-[N-cyclopropyl-S-(trifluoromethyl)sulfonimidoyl]-3-methyl-imidazo[4,5-b]pyridin-2-yl]-5-ethylsulfonyl-3-pyridyl]cyclopropanecarbonitrile (compound P58) 2. The compound of formula I according to claim 1, selected from the group consisting of:
22. A composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) according to any one of claims 1 to 21 or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, and optionally an auxiliary or diluent.
23. A method for combating and controlling insects, acaridae, nematodes or molluscs, comprising the step of applying to the pest, the pest's habitat or plants susceptible to attack by the pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any one of claims 1 to 21 or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof, or a composition as defined in claim 22.
24. 23. A method for protecting plant propagation material from attack by insects, mites, nematodes or mollusks, comprising treating the propagation material or the locus in which the propagation material is planted with a composition according to claim 22.
Citation Information
Patent Citations
Condensed heterocyclic compound and use thereof for pest control
JP2014005263A
Pesticidal active polycyclic derivatives with sulfur-containing substituents
JP2018507184A
Pest control composition and use therefor
JP2019006686A
